BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532. [PMID: 2841597 DOI: 10.1056/nejm198809013190901] [Cited by in Crossref: 4353] [Cited by in F6Publishing: 1399] [Article Influence: 131.9] [Reference Citation Analysis]
Number Citing Articles
1 Tikidzhieva A, Benner A, Michel S, Formentini A, Link KH, Dippold W, von Knebel Doeberitz M, Kornmann M, Kloor M. Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial. Br J Cancer. 2012;106:1239-1245. [PMID: 22353804 DOI: 10.1038/bjc.2012.53] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
2 Ponz de Leon M, Scapoli C, Zanghieri G, Sassatelli R, Sacchetti C, Barrai I. Genetic transmission of colorectal cancer: exploratory data analysis from a population based registry. J Med Genet 1992;29:531-8. [PMID: 1518021 DOI: 10.1136/jmg.29.8.531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
3 Fossum B, Olsen AC, Thorsby E, Gaudernack G. CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (Gly13-->Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer Immunol Immunother 1995;40:165-72. [PMID: 7728775 DOI: 10.1007/BF01517348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.0] [Reference Citation Analysis]
4 Wong HL, Ng LPW, Koh SP, Chan LWC, Wong EYK, Xue VW, Tsang HFA, Chan AKC, Chiu KY, Cheuk W, Wong SCC. Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells. Oncotarget 2018;9:20426-38. [PMID: 29755662 DOI: 10.18632/oncotarget.24921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ganeshan D, Elsayes KM, Vining D. Virtual colonoscopy: Utility, impact and overview. World J Radiol 2013;5:61-7. [PMID: 23671742 DOI: 10.4329/wjr.v5.i3.61] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
6 Gemoll T, Kollbeck SL, Karstens KF, Hò GG, Hartwig S, Strohkamp S, Schillo K, Thorns C, Oberländer M, Kalies K, Lehr S, Habermann JK. EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer. Oncotarget 2017;8:54939-50. [PMID: 28903393 DOI: 10.18632/oncotarget.18978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Allen JE, El-Deiry WS. Regulation of the human TRAIL gene. Cancer Biol Ther 2012;13:1143-51. [PMID: 22892844 DOI: 10.4161/cbt.21354] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
8 Osborne RJ, Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 1994;69:429-38. [PMID: 8123469 DOI: 10.1038/bjc.1994.79] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 2.0] [Reference Citation Analysis]
9 Stastna M, Janeckova L, Hrckulak D, Kriz V, Korinek V. Human Colorectal Cancer from the Perspective of Mouse Models. Genes (Basel) 2019;10:E788. [PMID: 31614493 DOI: 10.3390/genes10100788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 March HN, Rust AG, Wright NA, ten Hoeve J, de Ridder J, Eldridge M, van der Weyden L, Berns A, Gadiot J, Uren A, Kemp R, Arends MJ, Wessels LF, Winton DJ, Adams DJ. Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet. 2011;43:1202-1209. [PMID: 22057237 DOI: 10.1038/ng.990] [Cited by in Crossref: 143] [Cited by in F6Publishing: 124] [Article Influence: 14.3] [Reference Citation Analysis]
11 End DW. Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway. Invest New Drugs 1999;17:241-58. [PMID: 10665477 DOI: 10.1023/a:1006380320290] [Cited by in Crossref: 75] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
12 Rasmussen SL, Krarup HB, Sunesen KG, Johansen MB, Stender MT, Pedersen IS, Madsen PH, Thorlacius-Ussing O. The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer. Oncotarget 2018;9:7010-22. [PMID: 29467946 DOI: 10.18632/oncotarget.24097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
13 Karagkounis G, Torbenson MS, Daniel HD, Azad NS, Diaz LA Jr, Donehower RC, Hirose K, Ahuja N, Pawlik TM, Choti MA. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer. 2013;119:4137-4144. [PMID: 24104864 DOI: 10.1002/cncr.28347] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 14.3] [Reference Citation Analysis]
14 Kent OA, Fox-Talbot K, Halushka MK. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013;32:2576-85. [PMID: 22751122 DOI: 10.1038/onc.2012.266] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 10.2] [Reference Citation Analysis]
15 Kuick RD, Neel JV, Strahler JR, Chu EH, Bargal R, Fox DA, Hanash SM. Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis. Proc Natl Acad Sci U S A 1992;89:7036-40. [PMID: 1495998 DOI: 10.1073/pnas.89.15.7036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ebner F, Schremmer-Danninger E, Rehbock J. The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort. J Cancer Res Clin Oncol 2010;136:1369-75. [PMID: 20127253 DOI: 10.1007/s00432-010-0788-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sugio K, Molberg K, Albores-Saavedra J, Virmani AK, Kishimoto Y, Gazdar AF. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers. Int J Pancreatol 1997;21:205-17. [PMID: 9322119 DOI: 10.1007/BF02821606] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
18 Suzuki Y, Honma T, Hayashi S, Ajioka Y, Asakura H. Bcl-2 expression and frequency of apoptosis correlate with morphogenesis of colorectal neoplasia. J Clin Pathol. 2002;55:212-216. [PMID: 11896074 DOI: 10.1136/jcp.55.3.212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kushnir VM, Nalbantoglu I, Watson R, Goodwin J, Safar E, Chokshi RV, Azar RR, Davidson NO. Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci. 2014;59:2757-2764. [PMID: 24925148 DOI: 10.1007/s10620-014-3245-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
20 Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J Gastroenterol. 2014;20:13833-13841. [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
21 Lee J, Jain A, Kim P, Lee T, Kuller A, Princen F, In-GuDo, Kim SH, Park JO, Park YS, Singh S, Kim HC. Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. PLoS One 2014;9:e103551. [PMID: 25090459 DOI: 10.1371/journal.pone.0103551] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
22 Fujiki H, Suttajit M, Rawangkan A, Iida K, Limtrakul P, Umsumarng S, Suganuma M. Phorbol esters in seed oil of Jatropha curcas L. (saboodam in Thai) and their association with cancer prevention: from the initial investigation to the present topics. J Cancer Res Clin Oncol 2017;143:1359-69. [PMID: 28124725 DOI: 10.1007/s00432-017-2341-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
23 Friedrich T, Leong S, Lieu CH. Beyond RAS and BRAF: a target rich disease that is ripe for picking. J Gastrointest Oncol 2016;7:705-12. [PMID: 27747084 DOI: 10.21037/jgo.2016.06.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9:2642-2649. [PMID: 14669304 DOI: 10.3748/wjg.v9.i12.2642] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 68] [Article Influence: 4.9] [Reference Citation Analysis]
25 Zhu QC, Gao RY, Wu W, Guo BM, Peng JY, Qin HL. Effect of a high-fat diet in development of colonic adenoma in an animal model. World J Gastroenterol 2014;20:8119-29. [PMID: 25009384 DOI: 10.3748/wjg.v20.i25.8119] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
26 Yang Y, Lin X, Lu X, Luo G, Zeng T, Tang J, Jiang F, Li L, Cui X, Huang W, Hou G, Chen X, Ouyang Q, Tang S, Sun H, Chen L, Gonzalez FJ, Wu M, Cong W, Chen L, Wang H. Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis. Gut. 2016;65:1186-1201. [PMID: 26860770 DOI: 10.1136/gutjnl-2015-310318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
27 Grady WM, Pritchard CC. Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol 2014;42:124-39. [PMID: 24178577 DOI: 10.1177/0192623313505155] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
28 Buchanan DD, Roberts A, Walsh MD, Parry S, Young JP. Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer. Future Oncol 2010;6:539-49. [PMID: 20373868 DOI: 10.2217/fon.10.16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Ashburn JH, Plesec TP, Kalady MF. Serrated Polyps and Serrated Polyposis Syndrome. Clin Colon Rectal Surg 2016;29:336-44. [PMID: 31777465 DOI: 10.1055/s-0036-1584088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
30 Jia X, Shanmugam C, Paluri RK, Jhala NC, Behring MP, Katkoori VR, Sugandha SP, Bae S, Samuel T, Manne U. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Oncotarget 2017;8:20198-212. [PMID: 28423626 DOI: 10.18632/oncotarget.15560] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Numata M, Shiozawa M, Watanabe T, Tamagawa H, Yamamoto N, Morinaga S, Watanabe K, Godai T, Oshima T, Fujii S, Kunisaki C, Rino Y, Masuda M, Akaike M. The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol 2012;10:109. [PMID: 22703761 DOI: 10.1186/1477-7819-10-109] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
32 Umezawa S, Higurashi T, Komiya Y, Arimoto J, Horita N, Kaneko T, Iwasaki M, Nakagama H, Nakajima A. Chemoprevention of colorectal cancer: Past, present, and future. Cancer Sci 2019;110:3018-26. [PMID: 31361372 DOI: 10.1111/cas.14149] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
33 Iida S, Kato S, Ishiguro M, Matsuyama T, Ishikawa T, Kobayashi H, Higuchi T, Uetake H, Enomoto M, Sugihara K. PIK3CA mutation and methylation influences the outcome of colorectal cancer. Oncol Lett. 2012;3:565-570. [PMID: 22740953 DOI: 10.3892/ol.2011.544] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
34 Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A 1993;90:3221-5. [PMID: 8475062 DOI: 10.1073/pnas.90.8.3221] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 3.4] [Reference Citation Analysis]
35 Oh JH, Jang SJ, Kim J, Sohn I, Lee JY, Cho EJ, Chun SM, Sung CO. Spontaneous mutations in the single TTN gene represent high tumor mutation burden. NPJ Genom Med 2020;5:33. [PMID: 32821429 DOI: 10.1038/s41525-019-0107-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 16.0] [Reference Citation Analysis]
36 Obuch JC, Pigott CM, Ahnen DJ. Sessile serrated polyps: detection, eradication, and prevention of the evil twin. Curr Treat Options Gastroenterol 2015;13:156-70. [PMID: 25623474 DOI: 10.1007/s11938-015-0046-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
37 Yamagata S, Muto T, Uchida Y, Masaki T, Sawada T, Tsuno N, Hirooka T. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn J Cancer Res 1994;85:147-51. [PMID: 8144396 DOI: 10.1111/j.1349-7006.1994.tb02075.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 3.0] [Reference Citation Analysis]
38 Tomita N, Ishida H, Tanakaya K, Yamaguchi T, Kumamoto K, Tanaka T, Hinoi T, Miyakura Y, Hasegawa H, Takayama T, Ishikawa H, Nakajima T, Chino A, Shimodaira H, Hirasawa A, Nakayama Y, Sekine S, Tamura K, Akagi K, Kawasaki Y, Kobayashi H, Arai M, Itabashi M, Hashiguchi Y, Sugihara K; Japanese Society for Cancer of the Colon, Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol 2021;26:1353-419. [PMID: 34185173 DOI: 10.1007/s10147-021-01881-4] [Reference Citation Analysis]
39 Kim R, Schell MJ, Teer JK, Greenawalt DM, Yang M, Yeatman TJ. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era. PLoS One 2015;10:e0126670. [PMID: 25974029 DOI: 10.1371/journal.pone.0126670] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
40 Colditz GA, Wei EK. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health 2012;33:137-56. [PMID: 22224878 DOI: 10.1146/annurev-publhealth-031811-124627] [Cited by in Crossref: 69] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
41 Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328-333. [PMID: 24522528 DOI: 10.1038/nature13038] [Cited by in Crossref: 911] [Cited by in F6Publishing: 766] [Article Influence: 130.1] [Reference Citation Analysis]
42 Lin CH, Lin JK, Chang SC, Chang YH, Chang HM, Liu JH, Li LH, Chen YT, Tsai SF, Chen WS. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan. J Biomed Sci. 2011;18:36. [PMID: 21645411 DOI: 10.1186/1423-0127-18-36] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
43 Sasahira T, Akama Y, Fujii K, Kuniyasu H. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch. 2005;446:411-415. [PMID: 15789216 DOI: 10.1007/s00428-005-1210-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 4.7] [Reference Citation Analysis]
44 Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer. 2002;87:630-634. [PMID: 12237773 DOI: 10.1038/sj.bjc.6600511] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
45 Pickhardt PJ, Kim DH, Pooler BD, Hinshaw JL, Barlow D, Jensen D, Reichelderfer M, Cash BD. Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol. 2013;14:711-720. [PMID: 23746988 DOI: 10.1016/s1470-2045(13)70216-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 37] [Article Influence: 11.1] [Reference Citation Analysis]
46 Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson JA. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA. 2006;103:2959-2964. [PMID: 16477031 DOI: 10.1073/pnas.0511271103] [Cited by in Crossref: 169] [Cited by in F6Publishing: 146] [Article Influence: 11.3] [Reference Citation Analysis]
47 Fanelli GN, Dal Pozzo CA, Depetris I, Schirripa M, Brignola S, Biason P, Balistreri M, Dal Santo L, Lonardi S, Munari G, Loupakis F, Fassan M. The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer. Cancer Cell Int. 2020;20:30. [PMID: 32015690 DOI: 10.1186/s12935-020-1117-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
48 Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterology Res. 2018;11:264-273. [PMID: 30116425 DOI: 10.14740/gr1062w] [Cited by in Crossref: 107] [Cited by in F6Publishing: 85] [Article Influence: 35.7] [Reference Citation Analysis]
49 Rowley S, Newbold KM, Gearty J, Keighley MR, Donovan IA, Neoptolemos JP. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer. World J Surg 1990;14:545-50; discussion 551. [PMID: 2200214 DOI: 10.1007/BF01658688] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Ng K, Kim R, Kesari S, Carter B, Chen CC. Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. J Neurooncol 2012;107:1-12. [PMID: 22002595 DOI: 10.1007/s11060-011-0714-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
51 Houlston RS. What we could do now: molecular pathology of colorectal cancer. Mol Pathol 2001;54:206-14. [PMID: 11477132 DOI: 10.1136/mp.54.4.206] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
52 Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu Z, Tang W, Gan L, Sun M, Li J. MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget 2015;6:25418-28. [PMID: 26317898 DOI: 10.18632/oncotarget.4456] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
53 Phillips SM, Barton CM, Lee SJ, Morton DG, Wallace DM, Lemoine NR, Neoptolemos JP. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer. 1994;70:1252-1257. [PMID: 7526887 DOI: 10.1038/bjc.1994.482] [Cited by in Crossref: 103] [Cited by in F6Publishing: 80] [Article Influence: 4.0] [Reference Citation Analysis]
54 Jia XD, Han C. Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats. World J Gastroenterol 2000;6:699-703. [PMID: 11819677 DOI: 10.3748/wjg.v6.i5.699] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
55 Arbeit JM. Molecules, cancer, and the surgeon. A review of molecular biology and its implications for surgical oncology. Ann Surg 1990;212:3-13. [PMID: 2194440 DOI: 10.1097/00000658-199007000-00002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
56 Lehman TA, Reddel R, Peiifer AM, Spillare E, Kaighn ME, Weston A, Gerwin BI, Harris CC. Oncogenes and tumor-suppressor genes. Environ Health Perspect 1991;93:133-44. [PMID: 1685442 DOI: 10.1289/ehp.9193133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
57 Fang DC, Luo YH, Yang SM, Li XA, Ling XL, Fang L. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol. 2002;8:787-791. [PMID: 12378616 DOI: 10.3748/wjg.v8.i5.787] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
58 Huang CI, Taki T, Higashiyama M, Kohno N, Miyake M. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung. Br J Cancer 2000;82:374-80. [PMID: 10646891 DOI: 10.1054/bjoc.1999.0929] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
59 De Maio G, Zama E, Rengucci C, Calistri D. What influences preneoplastic colorectal lesion recurrence? Oncotarget 2017;8:12406-16. [PMID: 27902488 DOI: 10.18632/oncotarget.13628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
60 Zhang ZF, Zeng ZS, Sarkis AS, Klimstra DS, Charytonowicz E, Pollack D, Vena J, Guillem J, Marshall JR, Cordon-Cardo C. Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Br J Cancer. 1995;71:888-893. [PMID: 7710960 DOI: 10.1038/bjc.1995.171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
61 Hatton JL, Yee LD. Clinical Use of PPARgamma Ligands in Cancer. PPAR Res 2008;2008:159415. [PMID: 19125177 DOI: 10.1155/2008/159415] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
62 Johnson TL, Moyer MP. Normal human colon cells suppress malignancy when fused with colon cancer cells. In Vitro Cell Dev Biol. 1990;26:1095-1100. [PMID: 2276997 DOI: 10.1007/bf02624446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
63 Hsiung PL, Wang T. In vivo biomarkers for targeting colorectal neoplasms. Cancer Biomark 2008;4:329-40. [PMID: 19126961 DOI: 10.3233/cbm-2008-4605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol. 2014;20:12391-12406. [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
65 Slebos RJ, Baas IO, Clement M, Polak M, Mulder JW, van den Berg FM, Hamilton SR, Offerhaus GJ. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma. Br J Cancer 1996;74:165-71. [PMID: 8688317 DOI: 10.1038/bjc.1996.333] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
66 Toma C, Díaz-Gay M, Soares de Lima Y, Arnau-Collell C, Franch-Expósito S, Muñoz J, Overs B, Bonjoch L, Carballal S, Ocaña T, Cuatrecasas M, Díaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Balaguer F, Rodríguez-Alcalde D, Fullerton JM, Castellví-Bel S. Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing. Clin Transl Gastroenterol 2019;10:e00100. [PMID: 31663907 DOI: 10.14309/ctg.0000000000000100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Gatcliffe TA, Monk BJ, Planutis K, Holcombe RF. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer. 2008;18:954-962. [PMID: 17986238 DOI: 10.1111/j.1525-1438.2007.01127.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
68 Iijima M, Banno K, Okawa R, Yanokura M, Iida M, Takeda T, Kunitomi-Irie H, Adachi M, Nakamura K, Umene K, Nogami Y, Masuda K, Tominaga E, Aoki D. Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer. Oncol Lett 2017;13:1063-70. [PMID: 28454214 DOI: 10.3892/ol.2017.5582] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
69 Schneider M, Scholtka B, Gottschalk U, Faiss S, Schatz D, Berghof-Jäger K, Steinberg P. Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1. Cancers (Basel) 2010;3:91-105. [PMID: 24212608 DOI: 10.3390/cancers3010091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
70 Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008;455:547-551. [PMID: 18794900 DOI: 10.1038/nature07179] [Cited by in Crossref: 445] [Cited by in F6Publishing: 405] [Article Influence: 34.2] [Reference Citation Analysis]
71 Andreu-Ballester JC, Galindo-Regal L, Hidalgo-Coloma J, Cuéllar C, García-Ballesteros C, Hurtado C, Uribe N, Del Carmen Martín M, Jiménez AI, López-Chuliá F, Llombart-Cussac A. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors. PLoS One 2020;15:e0243545. [PMID: 33326443 DOI: 10.1371/journal.pone.0243545] [Reference Citation Analysis]
72 Roberts BS, Hardigan AA, Moore DE, Ramaker RC, Jones AL, Fitz-Gerald MB, Cooper GM, Wilcox CM, Kimberly RP, Myers RM. Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing. Clin Cancer Res 2018;24:2092-9. [PMID: 29490987 DOI: 10.1158/1078-0432.CCR-17-1960] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
73 Park YM, Youn J, Cho CH, Kim SH, Lee JE. Circulating folate levels and colorectal adenoma: a case-control study and a meta-analysis. Nutr Res Pract 2017;11:419-29. [PMID: 28989579 DOI: 10.4162/nrp.2017.11.5.419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisburger JH, Sugimura T, Nagao M. Specific 5'-GGGA-3'-->5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci U S A 1995;92:910-4. [PMID: 7846077 DOI: 10.1073/pnas.92.3.910] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 3.8] [Reference Citation Analysis]
75 Mazeh H, Mizrahi I, Ilyayev N, Halle D, Brücher B, Bilchik A, Protic M, Daumer M, Stojadinovic A, Itzhak A, Nissan A. The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review. J Cancer 2013;4:281-95. [PMID: 23459799 DOI: 10.7150/jca.5836] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
76 Rose JS, Serna DS, Martin LK, Li X, Weatherby LM, Abdel-Misih S, Zhao W, Bekaii-Saab T. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma. Cancer 2012;118:6243-52. [PMID: 22674181 DOI: 10.1002/cncr.27666] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
77 Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal 2007;19:1465-72. [PMID: 17317101 DOI: 10.1016/j.cellsig.2007.01.017] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
78 Sprouffske K, Pepper JW, Maley CC. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) 2011;4:1135-44. [PMID: 21490131 DOI: 10.1158/1940-6207.CAPR-10-0374] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
79 Osumi H, Matsusaka S, Shinozaki E, Suenaga M, Mingyon M, Saiura A, Ueno M, Mizunuma N, Yamaguchi T. Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report. BMC Res Notes 2013;6:508. [PMID: 24304820 DOI: 10.1186/1756-0500-6-508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
80 Watari J, Tanaka A, Tanabe H, Sato R, Moriichi K, Zaky A, Okamoto K, Maemoto A, Fujiya M, Ashida T. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer. J Clin Pathol. 2007;60:921-926. [PMID: 16997920 DOI: 10.1136/jcp.2006.041939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
81 Friedenberg FK, Singh M, George NS, Sankineni A, Shah S. Prevalence and distribution of adenomas in black Americans undergoing colorectal cancer screening. Dig Dis Sci 2012;57:489-95. [PMID: 22052446 DOI: 10.1007/s10620-011-1952-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
82 Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer. 2005;93:799-803. [PMID: 16091756 DOI: 10.1038/sj.bjc.6602743] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
83 Uchida H, Ando H, Maruyama K, Kobayashi H, Toda H, Ogawa H, Ozawa T, Matsuda Y, Sugimura H, Kanno T, Baba S. Genetic alterations of mixed hyperplastic adenomatous polyps in the colon and rectum. Jpn J Cancer Res 1998;89:299-306. [PMID: 9600124 DOI: 10.1111/j.1349-7006.1998.tb00562.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
84 Fittall MW, Van Loo P. Translating insights into tumor evolution to clinical practice: promises and challenges. Genome Med 2019;11:20. [PMID: 30925887 DOI: 10.1186/s13073-019-0632-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
85 Day LW, Velayos F. Colorectal cancer of the elderly. Curr Treat Options Gastroenterol 2014;12:269-82. [PMID: 24938590 DOI: 10.1007/s11938-014-0021-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
86 El Zoghbi M, Cummings LC. New era of colorectal cancer screening. World J Gastrointest Endosc 2016;8:252-8. [PMID: 26981176 DOI: 10.4253/wjge.v8.i5.252] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
87 Tatsuta M, Iishi H, Baba M, Uehara H, Nakaizumi A, Taniguchi H. Enhancing effects of calcium-deficient diet on gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Jpn J Cancer Res 1993;84:945-50. [PMID: 8407560 DOI: 10.1111/j.1349-7006.1993.tb00182.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
88 Izukuri K, Suzuki K, Yajima N, Ozawa S, Ito S, Kubota E, Hata R. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected]. Transgenic Res 2010;19:1109-17. [PMID: 20333465 DOI: 10.1007/s11248-010-9384-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
89 Zhou S, Lu J, Li Y, Chen C, Cai Y, Tan G, Peng Z, Zhang Z, Dong Z, Kang T, Tang F. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance. J Exp Clin Cancer Res 2018;37:284. [PMID: 30477538 DOI: 10.1186/s13046-018-0956-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
90 Ou B, Zhao J, Guan S, Lu A. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis. Dig Dis Sci 2016;61:881-9. [PMID: 26518415 DOI: 10.1007/s10620-015-3940-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
91 Vithayathil M, Smith S, Goryachev S, Nayor J, Song M. Development of a Large Colonoscopy-Based Longitudinal Cohort for Integrated Research of Colorectal Cancer: Partners Colonoscopy Cohort. Dig Dis Sci 2021. [PMID: 33590405 DOI: 10.1007/s10620-021-06882-x] [Reference Citation Analysis]
92 Takaku H, Ajioka Y, Watanabe H, Hashidate H, Yamada S, Yokoyama J, Kazama S, Suda T, Hatakeyama K. Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis. Jpn J Cancer Res 2001;92:119-26. [PMID: 11223540 DOI: 10.1111/j.1349-7006.2001.tb01073.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
93 Ohnishi T, Tomita N, Monden T, Ohue M, Yana I, Takami K, Yamamoto H, Yagyu T, Kikkawa N, Shimano T, Monden M. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma. Br J Cancer 1997;75:341-7. [PMID: 9020477 DOI: 10.1038/bjc.1997.56] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
94 Scott N, Martin I, Jack AS, Dixon MF, Quirke P. Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia. Clin Mol Pathol 1996;49:M151-8. [PMID: 16696064 DOI: 10.1136/mp.49.3.m151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De Pol A. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1-18. [PMID: 10741640 DOI: 10.1046/j.1365-2184.2000.00159.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
96 Miyano S, Hanazawa K, Kitabatake T, Fujisawa M, Kojima K. Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCR. Exp Ther Med 2012;4:790-4. [PMID: 23226727 DOI: 10.3892/etm.2012.694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
97 Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Rev Anticancer Ther 2009;9:1135-44. [PMID: 19671033 DOI: 10.1586/era.09.76] [Cited by in Crossref: 92] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
98 Morkel M, Riemer P, Bläker H, Sers C. Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance. Oncotarget 2015;6:20785-800. [PMID: 26299805 DOI: 10.18632/oncotarget.4750] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
99 Lee SE, Jo HB, Kwack WG, Jeong YJ, Yoon YJ, Kang HW. Characteristics of and risk factors for colorectal neoplasms in young adults in a screening population. World J Gastroenterol 2016;22:2981-92. [PMID: 26973394 DOI: 10.3748/wjg.v22.i10.2981] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
100 Lin PC, Lin JK, Lin HH, Lan YT, Lin CC, Yang SH, Chen WS, Liang WY, Jiang JK, Chang SC. A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer. World J Surg Oncol 2015;13:186. [PMID: 25986931 DOI: 10.1186/s12957-015-0601-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
101 Chang LC, Chiu HM, Shun CT, Liang JT, Lin JT, Chen CC, Lee YC, Wu MS. Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA. BMC Gastroenterol. 2014;14:221. [PMID: 25551625 DOI: 10.1186/s12876-014-0221-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
102 Park YM, Kim HS, Park JJ, Baik SJ, Youn YH, Kim JH, Park H. A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40-49 years. BMC Gastroenterol. 2017;17:7. [PMID: 28068908 DOI: 10.1186/s12876-016-0562-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
103 Kühl Svoboda Baldin R, Austrália Paredes Marcondes Ribas C, de Noronha L, Veloso da Silva-Camargo CC, Santos Sotomaior V, Martins Sebastião AP, Vasconcelos de Castilho AP, Rodrigues Montemor Netto M. Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps. J Histochem Cytochem 2021;69:437-49. [PMID: 34126796 DOI: 10.1369/00221554211026296] [Reference Citation Analysis]
104 Iyer DN, Wan TM, Man JH, Sin RW, Li X, Lo OS, Foo DC, Pang RW, Law WL, Ng L. Small RNA Profiling of piRNAs in Colorectal Cancer Identifies Consistent Overexpression of piR-24000 That Correlates Clinically with an Aggressive Disease Phenotype. Cancers (Basel) 2020;12:E188. [PMID: 31940941 DOI: 10.3390/cancers12010188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
105 Wen J, Liu X, Qi Y, Niu F, Niu Z, Geng W, Zou Z, Huang R, Wang J, Zou H. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways. J Exp Clin Cancer Res 2019;38:428. [PMID: 31665064 DOI: 10.1186/s13046-019-1435-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
106 Cooper O, Isacson O. Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J Neurosci 2004;24:8924-31. [PMID: 15483111 DOI: 10.1523/JNEUROSCI.2344-04.2004] [Cited by in Crossref: 119] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
107 McFerran E, O'Mahony JF, Fallis R, McVicar D, Zauber AG, Kee F. Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy. Epidemiol Rev. 2017;39:148-160. [PMID: 28402402 DOI: 10.1093/epirev/mxx002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
108 Chou CL, Lin JK, Wang HS, Yang SH, Li AF, Chang SC. Microsatellite instability screening should be done for right-sided colon cancer patients less than 60 years of age. Int J Colorectal Dis 2010;25:47-52. [PMID: 19847445 DOI: 10.1007/s00384-009-0815-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
109 Chen T, Wang Z, Zhou W, Chong Z, Meric-Bernstam F, Mills GB, Chen K. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types. BMC Genomics 2016;17 Suppl 2:394. [PMID: 27356755 DOI: 10.1186/s12864-016-2727-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
110 Oberholzer PA, Kee D, Dziunycz P, Sucker A, Kamsukom N, Jones R, Roden C, Chalk CJ, Ardlie K, Palescandolo E, Piris A, MacConaill LE, Robert C, Hofbauer GF, McArthur GA, Schadendorf D, Garraway LA. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. J Clin Oncol 2012;30:316-21. [PMID: 22067401 DOI: 10.1200/JCO.2011.36.7680] [Cited by in Crossref: 285] [Cited by in F6Publishing: 116] [Article Influence: 28.5] [Reference Citation Analysis]
111 Swift A, Risk JM, Kingsnorth AN, Wright TA, Myskow M, Field JK. Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Br J Cancer 1995;71:995-8. [PMID: 7734326 DOI: 10.1038/bjc.1995.191] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
112 Lynch HT, Fusaro RM, Lynch JF, Brand R. Pancreatic cancer and the FAMMM syndrome. Familial Cancer 2008;7:103-12. [DOI: 10.1007/s10689-007-9166-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
113 Matsumoto K, Iwase T, Hirono I, Nishida Y, Iwahori Y, Hori T, Asamoto M, Takasuka N, Kim DJ, Ushijima T, Nagao M, Tsuda H. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat. Jpn J Cancer Res. 1997;88:129-136. [PMID: 9119740 DOI: 10.1111/j.1349-7006.1997.tb00357.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
114 Amaro A, Angelini G, Mirisola V, Esposito AI, Reverberi D, Matis S, Maffei M, Giaretti W, Viale M, Gangemi R, Emionite L, Astigiano S, Cilli M, Bachmeier BE, Killian PH, Albini A, Pfeffer U. A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo. Oncotarget 2016;7:68803-20. [PMID: 27626697 DOI: 10.18632/oncotarget.11931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
115 Janku F, Lee JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Luthra R, Garrido-Laguna I, Kurzrock R. PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. PLoS One 2011;6:e22769. [PMID: 21829508 DOI: 10.1371/journal.pone.0022769] [Cited by in Crossref: 130] [Cited by in F6Publishing: 118] [Article Influence: 13.0] [Reference Citation Analysis]
116 Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli M, Blumberg AJ, Lasorella A, Nam DH, Finocchiaro G, Iavarone A, Rabadan R. Clonal evolution of glioblastoma under therapy. Nat Genet 2016;48:768-76. [PMID: 27270107 DOI: 10.1038/ng.3590] [Cited by in Crossref: 365] [Cited by in F6Publishing: 279] [Article Influence: 73.0] [Reference Citation Analysis]
117 Klingel R, Mittelstaedt P, Dippold WG, Meyer zum Büschenfelde KH. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease. Gut 1991;32:1508-13. [PMID: 1685466 DOI: 10.1136/gut.32.12.1508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
118 Koulis C, Yap R, Engel R, Jardé T, Wilkins S, Solon G, Shapiro JD, Abud H, McMurrick P. Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers (Basel) 2020;12:E812. [PMID: 32231042 DOI: 10.3390/cancers12040812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
119 Kim J, Al Faruque H, Kim S, Kim E, Hwang JY. Multimodal endoscopic system based on multispectral and photometric stereo imaging and analysis. Biomed Opt Express. 2019;10:2289-2302. [PMID: 31143492 DOI: 10.1364/boe.10.002289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
120 Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut. 2005;54:1283-1286. [PMID: 15843421 DOI: 10.1136/gut.2005.066514] [Cited by in Crossref: 149] [Cited by in F6Publishing: 126] [Article Influence: 9.3] [Reference Citation Analysis]
121 Jeon CH, Lee HI, Shin IH, Park JW. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients. Int J Colorectal Dis. 2008;23:29-35. [PMID: 17704924 DOI: 10.1007/s00384-007-0373-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
122 Chong ES. A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action. World J Microbiol Biotechnol. 2014;30:351-374. [PMID: 24068536 DOI: 10.1007/s11274-013-1499-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
123 Young M, Reed KR. Organoids as a Model for Colorectal Cancer. Curr Colorectal Cancer Rep 2016;12:281-7. [PMID: 27656116 DOI: 10.1007/s11888-016-0335-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
124 Hamada J, Takeichi N, Okada F, Ren J, Li X, Hosokawa M, Kobayashi H. Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res 1992;83:483-90. [PMID: 1618698 DOI: 10.1111/j.1349-7006.1992.tb01953.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
125 Spiotto MT, Reth MA, Schreiber H. Genetic changes occurring in established tumors rapidly stimulate new antibody responses. Proc Natl Acad Sci U S A 2003;100:5425-30. [PMID: 12702750 DOI: 10.1073/pnas.0930140100] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
126 Lambert DW, Wood IS, Ellis A, Shirazi-Beechey SP. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer. 2002;86:1262-1269. [PMID: 11953883 DOI: 10.1038/sj.bjc.6600264] [Cited by in Crossref: 100] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
127 Kihana T, Tsuda H, Teshima S, Okada S, Matsuura S, Hirohashi S. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn J Cancer Res. 1992;83:978-984. [PMID: 1429209 DOI: 10.1111/j.1349-7006.1992.tb02010.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 2.3] [Reference Citation Analysis]
128 Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status. Br J Cancer. 1994;69:732-737. [PMID: 8142262 DOI: 10.1038/bjc.1994.138] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]
129 Nguyen MN, Choi TG, Nguyen DT, Kim JH, Jo YH, Shahid M, Akter S, Aryal SN, Yoo JY, Ahn YJ, Cho KM, Lee JS, Choe W, Kang I, Ha J, Kim SS. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Oncotarget. 2015;6:31674-31692. [PMID: 26397224 DOI: 10.18632/oncotarget.5183] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
130 Westermark B. Glioblastoma--a moving target. Ups J Med Sci 2012;117:251-6. [PMID: 22512247 DOI: 10.3109/03009734.2012.676574] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
131 Burada F, Dumitrescu T, Nicoli R, Ciurea ME, Angelescu C, Mixich F, Ioana M. IL-1RN +2018T>C polymorphism is correlated with colorectal cancer. Mol Biol Rep. 2013;40:2851-2857. [PMID: 23192617 DOI: 10.1007/s11033-012-2300-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
132 Noguchi R, Yamaguchi K, Ikenoue T, Terakado Y, Ohta Y, Yamashita N, Kainuma O, Yokoi S, Maru Y, Nagase H, Furukawa Y. Genetic alterations in Japanese extrahepatic biliary tract cancer. Oncol Lett 2017;14:877-84. [PMID: 28693246 DOI: 10.3892/ol.2017.6224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
133 Hirsch D, Camps J, Varma S, Kemmerling R, Stapleton M, Ried T, Gaiser T. A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps. Genes Chromosomes Cancer 2012;51:490-500. [PMID: 22334367 DOI: 10.1002/gcc.21937] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
134 Worthley DL, Whitehall VL, Spring KJ, Leggett BA. Colorectal carcinogenesis: road maps to cancer. World J Gastroenterol 2007;13:3784-91. [PMID: 17657831 DOI: 10.3748/wjg.v13.i28.3784] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
135 Sugai T, Eizuka M, Habano W, Fujita Y, Sato A, Sugimoto R, Otsuka K, Yamamoto E, Matsumoto T, Suzuki H. Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers. Oncotarget 2018;9:22895-906. [PMID: 29796160 DOI: 10.18632/oncotarget.25112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Spisák S, Kalmár A, Galamb O, Wichmann B, Sipos F, Péterfia B, Csabai I, Kovalszky I, Semsey S, Tulassay Z. Genome-wide screening of genes regulated by DNA methylation in colon cancer development. PLoS One. 2012;7:e46215. [PMID: 23049694 DOI: 10.1371/journal.pone.0046215] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
137 Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K, Mahmood S. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians. Tumour Biol. 2013;34:1901-1911. [PMID: 23526092 DOI: 10.1007/s13277-013-0734-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
138 Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, Otsuka K, Nakamura S. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006;8:193-201. [PMID: 16645205 DOI: 10.2353/jmoldx.2006.050052] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 6.1] [Reference Citation Analysis]
139 Tsutsumi M, Murakami Y, Kondoh S, Tsujiuchi T, Hohnoki K, Horiguchi K, Noguchi O, Kobayashi E, Okita S, Sekiya T. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res 1993;84:956-60. [PMID: 8407562 DOI: 10.1111/j.1349-7006.1993.tb00184.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
140 Fukuyama T, Yamazaki T, Fujita T, Uematsu T, Ichiki Y, Kaneko H, Suzuki T, Kobayashi N. Helicobacter pylori, a carcinogen, induces the expression of melanoma antigen-encoding gene (Mage)-A3, a cancer/testis antigen. Tumour Biol 2012;33:1881-7. [PMID: 22773374 DOI: 10.1007/s13277-012-0448-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
141 Gonsalves WI, Mahoney MR, Sargent DJ, Nelson GD, Alberts SR, Sinicrope FA, Goldberg RM, Limburg PJ, Thibodeau SN, Grothey A, Hubbard JM, Chan E, Nair S, Berenberg JL, McWilliams RR; Alliance for Clinical Trials in Oncology. Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147. J Natl Cancer Inst 2014;106:dju106. [PMID: 24925349 DOI: 10.1093/jnci/dju106] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 12.9] [Reference Citation Analysis]
142 Coda S, Thompson AJ, Kennedy GT, Roche KL, Ayaru L, Bansi DS, Stamp GW, Thillainayagam AV, French PM, Dunsby C. Fluorescence lifetime spectroscopy of tissue autofluorescence in normal and diseased colon measured ex vivo using a fiber-optic probe. Biomed Opt Express 2014;5:515-38. [PMID: 24575345 DOI: 10.1364/BOE.5.000515] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 5.9] [Reference Citation Analysis]
143 Baker SJ, Vogelstein B. p53: a tumor suppressor hiding in plain sight. J Mol Cell Biol 2019;11:536-8. [PMID: 31276589 DOI: 10.1093/jmcb/mjz068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Lee CL, Huang CJ, Yang SH, Chang CC, Huang CC, Chien CC, Yang RN. Discovery of genes from feces correlated with colorectal cancer progression. Oncol Lett 2016;12:3378-84. [PMID: 27900008 DOI: 10.3892/ol.2016.5069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
145 Bonnington SN, Rutter MD. Surveillance of colonic polyps: Are we getting it right? World J Gastroenterol. 2016;22:1925-1934. [PMID: 26877600 DOI: 10.3748/wjg.v22.i6.1925] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
146 Keysselt K, Kreutzmann T, Rother K, Kerner C, Krohn K, Przybilla J, Buske P, Löffler-Wirth H, Loeffler M, Galle J, Aust G. Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency. Oncogene 2017;36:2750-61. [PMID: 27941880 DOI: 10.1038/onc.2016.429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
147 Kopáčová M, Urban O, Cyrany J, Laco J, Bureš J, Rejchrt S, Bártová J, Tachecí I. Cronkhite-Canada syndrome: review of the literature. Gastroenterol Res Pract 2013;2013:856873. [PMID: 24369458 DOI: 10.1155/2013/856873] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
148 Zhou D, Yang L, Zheng L, Ge W, Li D, Zhang Y, Hu X, Gao Z, Xu J, Huang Y. Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. PLoS One. 2013;8:e53310. [PMID: 23301059 DOI: 10.1371/journal.pone.0053310] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
149 Alquati C, Prossomariti A, Piazzi G, Buttitta F, Bazzoli F, Laghi L, Ricciardiello L. Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact. Cancers (Basel) 2021;13:2081. [PMID: 33923068 DOI: 10.3390/cancers13092081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ribeiro-Samy S, Oliveira MI, Pereira-Veiga T, Muinelo-Romay L, Carvalho S, Gaspar J, Freitas PP, López-López R, Costa C, Diéguez L. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients. Sci Rep 2019;9:8032. [PMID: 31142796 DOI: 10.1038/s41598-019-44401-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 13.5] [Reference Citation Analysis]
151 Playle LC, Hicks DJ, Qualtrough D, Paraskeva C. Abrogation of the radiation-induced G2 checkpoint by the staurosporine derivative UCN-01 is associated with radiosensitisation in a subset of colorectal tumour cell lines. Br J Cancer 2002;87:352-8. [PMID: 12177808 DOI: 10.1038/sj.bjc.6600492] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
152 Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, Buchanan D, Young J. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a “fusion” pathway to colorectal cancer. Histopathology. 2006;49:121-131. [PMID: 16879389 DOI: 10.1111/j.1365-2559.2006.02466.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 150] [Article Influence: 12.1] [Reference Citation Analysis]
153 Luebeck GE, Hazelton WD, Curtius K, Maden SK, Yu M, Carter KT, Burke W, Lampe PD, Li CI, Ulrich CM, Newcomb PA, Westerhoff M, Kaz AM, Luo Y, Inadomi JM, Grady WM. Implications of Epigenetic Drift in Colorectal Neoplasia. Cancer Res 2019;79:495-504. [PMID: 30291105 DOI: 10.1158/0008-5472.CAN-18-1682] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
154 Li M, Peng F, Li G, Fu Y, Huang Y, Chen Z, Chen Y. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.Oncotarget. 2016;7:37226-37237. [PMID: 27191989 DOI: 10.18632/oncotarget.9362] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
155 Lang BJ, Guerrero-Giménez ME, Prince TL, Ackerman A, Bonorino C, Calderwood SK. Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond. Int J Mol Sci 2019;20:E4507. [PMID: 31514477 DOI: 10.3390/ijms20184507] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
156 Pothuraju R, Krishn SR, Gautam SK, Pai P, Ganguly K, Chaudhary S, Rachagani S, Kaur S, Batra SK. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. Cancers (Basel) 2020;12:E649. [PMID: 32168759 DOI: 10.3390/cancers12030649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
157 Ramburan A. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of   catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. Journal of Clinical Pathology 2005;58:44-50. [DOI: 10.1136/jcp.2004.019752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
158 Augenlicht LH, Taylor J, Anderson L, Lipkin M. Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer. Proc Natl Acad Sci U S A 1991;88:3286-9. [PMID: 1849648 DOI: 10.1073/pnas.88.8.3286] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
159 Burnett-Hartman AN, Newcomb PA, Hutter CM, Peters U, Passarelli MN, Schwartz MR, Upton MP, Zhu LC, Potter JD, Makar KW. Variation in the association between colorectal cancer susceptibility loci and colorectal polyps by polyp type. Am J Epidemiol 2014;180:223-32. [PMID: 24875374 DOI: 10.1093/aje/kwu114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
160 Lai MC, Chang CM, Sun HS. Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells. PLoS One 2016;11:e0153627. [PMID: 27078027 DOI: 10.1371/journal.pone.0153627] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
161 Nosho K, Yamamoto H, Takamaru H, Hamamoto Y, Goto A, Yoshida Y, Arimura Y, Endo T, Hirata K, Imai K. A case of colorectal carcinoma in adenoma analyzed by a cDNA array. Int J Colorectal Dis 2005;20:287-91. [PMID: 15490195 DOI: 10.1007/s00384-004-0656-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
162 Kim SH, Roth KA, Moser AR, Gordon JI. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol 1993;123:877-93. [PMID: 8227147 DOI: 10.1083/jcb.123.4.877] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
163 Tominaga O, Nita ME, Nagawa H, Muto T. Screening for APC mutations based on detection of truncated APC proteins. Dig Dis Sci 1998;43:306-10. [PMID: 9512122 DOI: 10.1023/a:1018846103834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
164 Draht MXG, Goudkade D, Koch A, Grabsch HI, Weijenberg MP, van Engeland M, Melotte V, Smits KM. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clin Epigenetics 2018;10:35. [PMID: 29564023 DOI: 10.1186/s13148-018-0461-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
165 Kim KH, Kim KO, Jung Y, Lee J, Kim SW, Kim JH, Kim TJ, Cho YS, Joo YE. Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study. Sci Rep 2019;9:3946. [PMID: 30850671 DOI: 10.1038/s41598-019-40559-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
166 Velazquez AI, McCoach CE. Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer. J Thorac Dis 2020;12:2896-909. [PMID: 32642202 DOI: 10.21037/jtd.2019.08.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Kelloff GJ, Sigman CC. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 2012;11:201-14. [PMID: 22322254 DOI: 10.1038/nrd3651] [Cited by in Crossref: 186] [Cited by in F6Publishing: 133] [Article Influence: 20.7] [Reference Citation Analysis]
168 Beg S, Wilson A, Ragunath K. The use of optical imaging techniques in the gastrointestinal tract. Frontline Gastroenterol 2016;7:207-15. [PMID: 27429735 DOI: 10.1136/flgastro-2015-100563] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
169 Pilbrow SJ, Hertzog PJ, Linnane AW. The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential. Br J Cancer 1992;66:748-57. [PMID: 1419617 DOI: 10.1038/bjc.1992.351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
170 Goggins M, Hruban RH, Kern SE. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am J Pathol 2000;156:1767-71. [PMID: 10793087 DOI: 10.1016/S0002-9440(10)65047-X] [Cited by in Crossref: 134] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
171 Wan TM, Iyer DN, Ng L. Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer. Histol Histopathol 2020;35:225-37. [PMID: 31617575 DOI: 10.14670/HH-18-171] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
172 Aka K, Bruner JM, Bondy ML, Ligon K, Nishi T, del Giglio A, Moser RP, Levin VA, Saya H. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction. J Neurooncol 1993;16:125-33. [PMID: 7904621 DOI: 10.1007/BF01324699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
173 Tsujino T, Yoshida K, Nakayama H, Ito H, Shimosato T, Tahara E. Alterations of oncogenes in metastatic tumours of human gastric carcinomas. Br J Cancer 1990;62:226-30. [PMID: 2386738 DOI: 10.1038/bjc.1990.265] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
174 Aslam MI, Patel M, Singh B, Jameson JS, Pringle JH. MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application. J Transl Med. 2012;10:128. [PMID: 22716183 DOI: 10.1186/1479-5876-10-128] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
175 Wang S, Wu S, Meng Q, Li X, Zhang J, Chen R, Wang M. FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin. Sci Rep 2016;6:19229. [PMID: 26759270 DOI: 10.1038/srep19229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
176 Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, Larson DE, McLellan MD, Dooling D, Abbott R. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366:1090-1098. [PMID: 22417201 DOI: 10.1056/nejmoa1106968] [Cited by in Crossref: 546] [Cited by in F6Publishing: 275] [Article Influence: 60.7] [Reference Citation Analysis]
177 Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schäfer R. Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol. 1997;136:935-944. [PMID: 9049257 DOI: 10.1083/jcb.136.4.935] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 3.0] [Reference Citation Analysis]
178 Inamura K. Colorectal Cancers: An Update on Their Molecular Pathology. Cancers (Basel). 2018;10. [PMID: 29361689 DOI: 10.3390/cancers10010026] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 20.7] [Reference Citation Analysis]
179 Barrett MT, Reid BJ, Joslyn G. Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res 1995;23:3488-92. [PMID: 7567460 DOI: 10.1093/nar/23.17.3488] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
180 Hwang MJ, Kim KO, Kim AL, Lee SH, Jang BI, Kim TN. Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice. Intest Res 2018;16:475-83. [PMID: 30090047 DOI: 10.5217/ir.2018.16.3.475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Sugai T, Habano W, Uesugi N, Jiao YF, Nakamura S, Sato K, Chiba T, Ishii M. Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn 2002;4:191-200. [PMID: 12411586 DOI: 10.1016/s1525-1578(10)60703-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
182 Waterston AM, Cassidy J. Adjuvant treatment strategies for early colon cancer. Drugs 2005;65:1935-47. [PMID: 16162019 DOI: 10.2165/00003495-200565140-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
183 Andreyev HJ, Tilsed JV, Cunningham D, Sampson SA, Norman AR, Schneider HJ, Clarke PA. K-ras mutations in patients with early colorectal cancers. Gut. 1997;41:323-329. [PMID: 9378386 DOI: 10.1136/gut.41.3.323] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
184 Kokelaar RF, Jones HG, Williamson J, Williams N, Griffiths AP, Beynon J, Jenkins GJ, Harris DA. DNA hypermethylation as a predictor of extramural vascular invasion (EMVI) in rectal cancer. Cancer Biol Ther 2018;19:214-21. [PMID: 29260978 DOI: 10.1080/15384047.2017.1416933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
185 Wilson BJ, Schatton T, Frank MH, Frank NY. Colorectal Cancer Stem Cells: Biology and Therapeutic Implications. Curr Colorectal Cancer Rep 2011;7:128-35. [PMID: 21552371 DOI: 10.1007/s11888-011-0093-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
186 Cerrito MG, Grassilli E. Identifying Novel Actionable Targets in Colon Cancer. Biomedicines 2021;9:579. [PMID: 34065438 DOI: 10.3390/biomedicines9050579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Hainke K, Szugat S, Fried R, Rahnenführer J. Variable selection for disease progression models: methods for oncogenetic trees and application to cancer and HIV. BMC Bioinformatics 2017;18:358. [PMID: 28764644 DOI: 10.1186/s12859-017-1762-1] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
188 Fang DC, Yang SM, Zhou XD, Wang DX, Luo YH. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenteol. 2001;7:522-526. [DOI: 10.3748/wjg.v7.i4.522] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
189 Youn A, Simon R. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data. Bioinformatics 2012;28:1555-61. [PMID: 22492649 DOI: 10.1093/bioinformatics/bts168] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
190 Okamoto M, Sato C, Kohno Y, Mori T, Iwama T, Tonomura A, Miki Y, Utsunomiya J, Nakamura Y, White R. Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis. Hum Genet 1990;85:595-9. [PMID: 2172153 DOI: 10.1007/BF00193581] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
191 Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci 2021;22:5246. [PMID: 34063506 DOI: 10.3390/ijms22105246] [Reference Citation Analysis]
192 Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ, Habbema JD. Individualizing colonoscopy screening by sex and race. Gastrointest Endosc 2009;70:96-108, 108.e1-24. [PMID: 19467539 DOI: 10.1016/j.gie.2008.08.040] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
193 Shahrabi Farahani H, Lagergren J. Learning oncogenetic networks by reducing to mixed integer linear programming. PLoS One 2013;8:e65773. [PMID: 23799047 DOI: 10.1371/journal.pone.0065773] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
194 Chen H, Qian J, Werner S, Cuk K, Knebel P, Brenner H. Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer. Clin Epidemiol. 2017;9:517-526. [PMID: 29184444 DOI: 10.2147/clep.s144171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
195 Syed Sameer A, Shah ZA, Abdullah S, Chowdri NA, Siddiqi MA. Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum Genomics. 2011;5:441-452. [PMID: 21807601 DOI: 10.1186/1479-7364-5-5-441] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
196 Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol. 1998;153:1063-1078. [PMID: 9777938 DOI: 10.1016/s0002-9440(10)65651-9] [Cited by in Crossref: 129] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
197 Li P, Lin JE, Marszlowicz GP, Valentino MA, Chang C, Schulz S, Pitari GM, Waldman SA. GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome? Drug News Perspect 2009;22:313-8. [PMID: 19771320 DOI: 10.1358/dnp.2009.22.6.1395254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
198 Mertz KD, Mager LF, Wasmer MH, Thiesler T, Koelzer VH, Ruzzante G, Joller S, Murdoch JR, Brümmendorf T, Genitsch V, Lugli A, Cathomas G, Moch H, Weber A, Zlobec I, Junt T, Krebs P. The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology 2016;5:e1062966. [PMID: 26942077 DOI: 10.1080/2162402X.2015.1062966] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
199 Hargest R, Williamson R. Expression of the APC gene after transfection into a colonic cancer cell line. Gut 1995;37:826-9. [PMID: 8537055 DOI: 10.1136/gut.37.6.826] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
200 Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study., Australian Ovarian Cancer Study Group., Ovarian Cancer Association Consortium. Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet 2015;47:888-97. [PMID: 26075790 DOI: 10.1038/ng.3336] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
201 Anand BS, Verstovsek G, Cole G. Tubulovillous adenoma of anal canal: a case report. World J Gastroenterol 2006;12:1780-1. [PMID: 16586552 DOI: 10.3748/wjg.v12.i11.1780] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
202 Choi PM, Tchou-Wong KM, Weinstein IB. Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 1990;10:4650-7. [PMID: 2388620 DOI: 10.1128/mcb.10.9.4650-4657.1990] [Cited by in Crossref: 127] [Article Influence: 4.1] [Reference Citation Analysis]
203 Lee YM, Huh KC. Clinical and Biological Features of Interval Colorectal Cancer. Clin Endosc 2017;50:254-60. [PMID: 28320200 DOI: 10.5946/ce.2016.115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
204 Goh V, Glynne-Jones R. Perfusion CT imaging of colorectal cancer. Br J Radiol. 2014;87:20130811. [PMID: 24434157 DOI: 10.1259/bjr.20130811] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
205 Wu W, Ye S, Tan W, Zhou Y, Quan J. Analysis of promoter methylation and epigenetic regulation of miR-32 in colorectal cancer cells. Exp Ther Med 2019;17:3209-14. [PMID: 30936995 DOI: 10.3892/etm.2019.7328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Chang SC, Li AF, Lin PC, Lin CC, Lin HH, Huang SC, Lin CH, Liang WY, Chen WS, Jiang JK, Lin JK, Yang SH, Lan YT. Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP). Cancers (Basel) 2020;12:E3487. [PMID: 33238621 DOI: 10.3390/cancers12113487] [Reference Citation Analysis]
207 Patai ÁV, Valcz G, Hollósi P, Kalmár A, Péterfia B, Patai Á, Wichmann B, Spisák S, Barták BK, Leiszter K, Tóth K, Sipos F, Kovalszky I, Péter Z, Miheller P, Tulassay Z, Molnár B. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas. PLoS One. 2015;10:e0133836. [PMID: 26291085 DOI: 10.1371/journal.pone.0133836] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
208 de Paiva Haddad LB, Patzina RA, Penteado S, Montagnini AL, da Cunha JE, Machado MC, Jukemura J. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. J Gastrointest Surg. 2010;14:719-728. [PMID: 20107918 DOI: 10.1007/s11605-010-1156-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
209 Clarke MA, Fisher J. Executable cancer models: successes and challenges. Nat Rev Cancer 2020;20:343-54. [PMID: 32341552 DOI: 10.1038/s41568-020-0258-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 18.0] [Reference Citation Analysis]
210 Marino M. Xenoestrogens challenge 17β-estradiol protective effects in colon cancer. World J Gastrointest Oncol 2014;6:67-73. [PMID: 24653796 DOI: 10.4251/wjgo.v6.i3.67] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
211 Chaiyawat P, Netsirisawan P, Svasti J, Champattanachai V. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer. Front Endocrinol (Lausanne) 2014;5:193. [PMID: 25426101 DOI: 10.3389/fendo.2014.00193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
212 Varesco L, Thomas HJ, Cottrell S, Murday V, Fennell SJ, Williams S, Searle S, Sheer D, Bodmer WF, Frischauf AM. CpG island clones from a deletion encompassing the gene for adenomatous polyposis coli. Proc Natl Acad Sci U S A 1989;86:10118-22. [PMID: 2557613 DOI: 10.1073/pnas.86.24.10118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 0.4] [Reference Citation Analysis]
213 Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 2004;90:1030-3. [PMID: 14997203 DOI: 10.1038/sj.bjc.6601647] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
214 Weijenberg MP, Lüchtenborg M, de Goeij AF, Brink M, van Muijen GN, de Bruïne AP, Goldbohm RA, van den Brandt PA. Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes Control 2007;18:865-79. [PMID: 17636402 DOI: 10.1007/s10552-007-9032-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
215 Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut. 2002;51 Suppl 5:V6-V9. [PMID: 12221031 DOI: 10.1136/gut.51.suppl_5.v6] [Cited by in Crossref: 192] [Cited by in F6Publishing: 157] [Article Influence: 10.1] [Reference Citation Analysis]
216 Park S, Ahn HK, Lee DH, Jung Y, Jeong JW, Nam S, Lee WS. Systematic mutation analysis in rare colorectal cancer presenting ovarian metastases. Sci Rep 2019;9:16990. [PMID: 31740709 DOI: 10.1038/s41598-019-53182-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
217 Kihana T, Tsuda H, Hirota T, Shimosato Y, Sakamoto H, Terada M, Hirohashi S. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res. 1991;82:308-314. [PMID: 1902452 DOI: 10.1111/j.1349-7006.1991.tb01847.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 1.8] [Reference Citation Analysis]
218 Todaro M, Orlando V, Cicero G, Caccamo N, Meraviglia S, Stassi G, Dieli F. Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity. PLoS One 2013;8:e65145. [PMID: 23762301 DOI: 10.1371/journal.pone.0065145] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
219 Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA. 1990;87:8751-8755. [PMID: 1978938 DOI: 10.1073/pnas.87.22.8751] [Cited by in Crossref: 294] [Cited by in F6Publishing: 267] [Article Influence: 9.8] [Reference Citation Analysis]
220 Gruis NA, Abeln EC, Bardoel AF, Devilee P, Frants RR, Cornelisse CJ. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer. 1993;68:308-313. [PMID: 8102243 DOI: 10.1038/bjc.1993.333] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 1.7] [Reference Citation Analysis]
221 Haque TR, Bradshaw PT, Crockett SD. Risk factors for serrated polyps of the colorectum. Dig Dis Sci. 2014;59:2874-2889. [PMID: 25030942 DOI: 10.1007/s10620-014-3277-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
222 Wojtkowiak JW, Gibbs RA, Mattingly RR. Working together: Farnesyl transferase inhibitors and statins block protein prenylation. Mol Cell Pharmacol 2009;1:1-6. [PMID: 20419048 DOI: 10.4255/mcpharmacol.09.01] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
223 De Nicola F, Goeman F, Pallocca M, Sperati F, Pizzuti L, Melucci E, Casini B, Amoreo CA, Gallo E, Diodoro MG, Buglioni S, Mazzotta M, Vici P, Sergi D, Di Lauro L, Barba M, Pescarmona E, Ciliberto G, De Maria R, Fanciulli M, Maugeri-Saccà M. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer. Oncogenesis 2018;7:55. [PMID: 30032163 DOI: 10.1038/s41389-018-0066-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
224 Mulder JW, Wielenga VJ, Polak MM, van den Berg FM, Adolf GR, Herrlich P, Pals ST, Offerhaus GJ. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut. 1995;36:76-80. [PMID: 7534253 DOI: 10.1136/gut.36.1.76] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 1.4] [Reference Citation Analysis]
225 Burum-Auensen E, DeAngelis PM, Schjølberg AR, Røislien J, Mjåland O, Clausen OP. Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers. Cell Prolif 2008;41:645-59. [PMID: 18699967 DOI: 10.1111/j.1365-2184.2008.00539.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
226 Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299-306. [PMID: 22009989 DOI: 10.1101/gr.126516.111] [Cited by in Crossref: 961] [Cited by in F6Publishing: 816] [Article Influence: 96.1] [Reference Citation Analysis]
227 Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW. Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer. J Transl Med 2015;13:217. [PMID: 26149458 DOI: 10.1186/s12967-015-0531-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
228 Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 2018;27:158-64. [PMID: 29150480 DOI: 10.1158/1055-9965.EPI-17-0378] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
229 Peng F, Huang Y, Li MY, Li GQ, Huang HC, Guan R, Chen ZC, Liang SP, Chen YH. Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer. World J Gastroenterol. 2016;22:4515-4528. [PMID: 27182161 DOI: 10.3748/wjg.v22.i18.4515] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
230 Muta Y, Fujita Y, Sumiyama K, Sakurai A, Taketo MM, Chiba T, Seno H, Aoki K, Matsuda M, Imajo M. Composite regulation of ERK activity dynamics underlying tumour-specific traits in the intestine. Nat Commun 2018;9:2174. [PMID: 29872037 DOI: 10.1038/s41467-018-04527-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
231 Hata K, Watanabe T, Kawamura YJ, Ishigami H, Kanazawa T, Tada T, Zhao B, Koketsu S, Nagawa H. K-ras mutation and loss of heterozygosity at 17p with beta-catenin accumulation in intramucosal carcinoma of the ileostomy in familial adenomatous polyposis: a case report. Dig Dis Sci. 2003;48:2310-2314. [PMID: 14714618 DOI: 10.1023/b: ddas.0000007868.52339.22] [Reference Citation Analysis]
232 Hartmans E, Orian-Rousseau V, Matzke-Ogi A, Karrenbeld A, de Groot DJ, de Jong S, van Dam GM, Fehrmann RS, Nagengast WB. Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets. Theranostics 2017;7:482-92. [PMID: 28255344 DOI: 10.7150/thno.16816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
233 Hahn MM, de Voer RM, Hoogerbrugge N, Ligtenberg MJ, Kuiper RP, van Kessel AG. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell Oncol (Dordr) 2016;39:491-510. [PMID: 27279102 DOI: 10.1007/s13402-016-0284-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
234 Kurman RJ, McConnell TG. Precursors of endometrial and ovarian carcinoma. Virchows Arch 2010;456:1-12. [PMID: 19859732 DOI: 10.1007/s00428-009-0824-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
235 Klos CL, Dharmarajan S. Polyp Genetics. Clin Colon Rectal Surg 2016;29:289-95. [PMID: 31777459 DOI: 10.1055/s-0036-1582442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
236 Kelly KA, Jones DA. Isolation of a colon tumor specific binding peptide using phage display selection. Neoplasia. 2003;5:437-444. [PMID: 14670181 DOI: 10.1016/S1476-5586(03)80046-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
237 Maeyama Y, Mitsuyama K, Noda T, Nagata S, Nagata T, Yoshioka S, Yoshida H, Mukasa M, Sumie H, Kawano H, Akiba J, Araki Y, Kakuma T, Tsuruta O, Torimura T. Prediction of colorectal tumor grade and invasion depth through narrow-band imaging scoring. World J Gastroenterol 2018;24:4809-20. [PMID: 30479467 DOI: 10.3748/wjg.v24.i42.4809] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Yamada Y, Yoshimi N, Hirose Y, Hara A, Shimizu M, Kuno T, Katayama M, Qiao Z, Mori H. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib. Jpn J Cancer Res. 2001;92:617-623. [PMID: 11429049 DOI: 10.1111/j.1349-7006.2001.tb01139.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
239 Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, Rugge M. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch. 2011;458:413-419. [PMID: 21279518 DOI: 10.1007/s00428-011-1046-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
240 Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET. Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2012;21:368-75. [PMID: 22144504 DOI: 10.1158/1055-9965.EPI-11-0916] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
241 Saito T, Nibe K, Chambers JK, Uneyama M, Nakashima K, Ohno K, Tsujimoto H, Uchida K, Nakayama H. A histopathological study on spontaneous gastrointestinal epithelial tumors in dogs. J Toxicol Pathol 2020;33:105-13. [PMID: 32425343 DOI: 10.1293/tox.2019-0076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
242 Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res 1993;84:388-93. [PMID: 8514605 DOI: 10.1111/j.1349-7006.1993.tb00148.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.8] [Reference Citation Analysis]
243 Tsujiuchi T, Tsutsumi M, Kido A, Kobitsu K, Takahama M, Majima T, Denda A, Nakae D, Konishi Y. Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline-deficient L-amino acid-defined diet in rats. Jpn J Cancer Res 1996;87:1111-5. [PMID: 9045938 DOI: 10.1111/j.1349-7006.1996.tb03119.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
244 Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55:62-67. [PMID: 15972299 DOI: 10.1136/gut.2005.068189] [Cited by in Crossref: 243] [Cited by in F6Publishing: 203] [Article Influence: 15.2] [Reference Citation Analysis]
245 Umeto H, Yoshida T, Araki K, Yagishita H, Mikami T, Okayasu I. Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender. J Gastroenterol. 2009;44:1036-1045. [PMID: 19590931 DOI: 10.1007/s00535-009-0103-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
246 Liu G, Zhan X, Dong C, Liu L. Genomics alterations of metastatic and primary tissues across 15 cancer types. Sci Rep 2017;7:13262. [PMID: 29038591 DOI: 10.1038/s41598-017-13650-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
247 Nietzer S, Baur F, Sieber S, Hansmann J, Schwarz T, Stoffer C, Häfner H, Gasser M, Waaga-Gasser AM, Walles H, Dandekar G. Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold. Tissue Eng Part C Methods 2016;22:621-35. [PMID: 27137941 DOI: 10.1089/ten.TEC.2015.0557] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
248 Garborg K, de Lange T, Bretthauer M. Quality Indicators in Colonoscopy. Curr Treat Options Gastroenterol 2017;15:416-28. [PMID: 28702775 DOI: 10.1007/s11938-017-0140-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
249 Khan NP, Pandith AA, Hussain MU, Yousuf A, Khan MS, Wani KA, Mudassar S. Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population. Mol Cell Biochem 2011;355:149-55. [PMID: 21541676 DOI: 10.1007/s11010-011-0848-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
250 Evans HJ, Prosser J. Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers. Environ Health Perspect 1992;98:25-37. [PMID: 1336726 DOI: 10.1289/ehp.929825] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
251 Marshall JR. Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am 2008;37:73-82, vi. [PMID: 18313540 DOI: 10.1016/j.gtc.2007.12.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
252 Güllülü Ö, Hehlgans S, Rödel C, Fokas E, Rödel F. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions. Cancers (Basel) 2021;13:624. [PMID: 33557398 DOI: 10.3390/cancers13040624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Gossett RE, Schroeder F, Gunn JM, Kier AB. Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation. Lipids 1997;32:577-85. [PMID: 9208385 DOI: 10.1007/s11745-997-0073-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
254 Drew DA, Cao Y, Chan AT. Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer. 2016;16:173-186. [PMID: 26868177 DOI: 10.1038/nrc.2016.4] [Cited by in Crossref: 220] [Cited by in F6Publishing: 172] [Article Influence: 44.0] [Reference Citation Analysis]
255 Rocco A, Compare D, Nardone G. Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions. World J Gastrointest Oncol. 2012;4:54-59. [PMID: 22468184 DOI: 10.4251/wjgo.v4.i3.54] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
256 Siraj AK, Bu R, Prabhakaran S, Bavi P, Beg S, Al Hazmi M, Al-Rasheed M, Alobaisi K, Al-Dayel F, AlManea H, Al-Sanea N, Uddin S, Al-Kuraya KS. A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. Mol Cancer 2014;13:168. [PMID: 25005754 DOI: 10.1186/1476-4598-13-168] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
257 Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut. 1994;35:764-768. [PMID: 8020801 DOI: 10.1136/gut.35.6.764] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
258 Tao Y, Ruan J, Yeh SH, Lu X, Wang Y, Zhai W, Cai J, Ling S, Gong Q, Chong Z. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci USA. 2011;108:12042-12047. [PMID: 21730188 DOI: 10.1073/pnas.1108715108] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 10.0] [Reference Citation Analysis]
259 Nakayama R, Arikawa K, Bhawal UK. The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers. J Cancer 2017;8:3014-27. [PMID: 28928893 DOI: 10.7150/jca.21169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
260 Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2011;2:00078. [PMID: 22114584 DOI: 10.3389/fgene.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
261 Lee SS, Jung WT, Kim CY, Ha CY, Min HJ, Kim HJ, Kim TH. The synchronous prevalence of colorectal neoplasms in patients with stomach cancer. J Korean Soc Coloproctol 2011;27:246-51. [PMID: 22102975 DOI: 10.3393/jksc.2011.27.5.246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
262 Talamonti MS, Roh MS, Curley SA, Gallick GE. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest. 1993;91:53-60. [PMID: 7678609 DOI: 10.1172/jci116200] [Cited by in Crossref: 291] [Cited by in F6Publishing: 104] [Article Influence: 10.4] [Reference Citation Analysis]
263 Smith DR, Myint T, Goh HS. Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br J Cancer 1993;68:407-13. [PMID: 8347498 DOI: 10.1038/bjc.1993.350] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 1.9] [Reference Citation Analysis]
264 Capo-chichi CD, Cai KQ, Testa JR, Godwin AK, Xu XX. Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol 2009;29:4766-77. [PMID: 19581290 DOI: 10.1128/MCB.00087-09] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
265 Inoue K, Kurabayashi A, Shuin T, Ohtsuki Y, Furihata M. Overexpression of p53 protein in human tumors. Med Mol Morphol. 2012;45:115-123. [PMID: 23001293 DOI: 10.1007/s00795-012-0575-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
266 Ramel S. Barrett's esophagus: model of neoplastic progression. World J Surg. 2003;27:1009-1013. [PMID: 12917763 DOI: 10.1007/s00268-003-7053-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
267 Naguib A, Mitrou PN, Gay LJ, Cooke JC, Luben RN, Ball RY, McTaggart A, Arends MJ, Rodwell SA. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. BMC Cancer. 2010;10:99. [PMID: 20233436 DOI: 10.1186/1471-2407-10-99] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
268 Croner RS, Foertsch T, Brueckl WM, Guenther K, Siebenhaar R, Stremmel C, Matzel KE, Papadopoulos T, Kirchner T, Behrens J, Klein-Hitpass L, Stuerzl M, Hohenberger W, Reingruber B. Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis 2005;20:353-62. [PMID: 15614505 DOI: 10.1007/s00384-004-0664-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
269 Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011;60:116-29. [PMID: 20921207 DOI: 10.1136/gut.2009.206250] [Cited by in Crossref: 210] [Cited by in F6Publishing: 188] [Article Influence: 19.1] [Reference Citation Analysis]
270 Hata K, Yamamoto Y, Kiyomatsu T, Tanaka T, Kazama S, Nozawa H, Kawai K, Tanaka J, Nishikawa T, Otani K. Hereditary gastrointestinal cancer. Surg Today. 2015; Dec 16. [Epub ahead of print]. [PMID: 26676416 DOI: 10.1007/s00595-015-1283-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
271 Servomaa K, Kiuru A, Kosma VM, Hirvikoski P, Rytömaa T. p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol 2000;53:24-30. [PMID: 10884918 DOI: 10.1136/mp.53.1.24] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
272 Barrett JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 1993;100:9-20. [PMID: 8354184 DOI: 10.1289/ehp.931009] [Cited by in Crossref: 140] [Cited by in F6Publishing: 108] [Article Influence: 5.0] [Reference Citation Analysis]
273 Burmer GC, Loeb LA. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA. 1989;86:2403-2407. [PMID: 2648401 DOI: 10.1073/pnas.86.7.2403] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 3.7] [Reference Citation Analysis]
274 Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol. 1998;51:593-596. [PMID: 9828817 DOI: 10.1136/jcp.51.8.593] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
275 Parchment RE, Natarajan K. A free-radical hypothesis for the instability and evolution of genotype and phenotype in vitro. Cytotechnology 1992;10:93-124. [PMID: 1369214 DOI: 10.1007/BF00570888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
276 Andreyev HJ, Ross PJ, Cunningham D, Clarke PA. Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma. Gut 2001;48:230-7. [PMID: 11156646 DOI: 10.1136/gut.48.2.230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
277 Schernhammer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology. 2008;135:770-780. [PMID: 18619459 DOI: 10.1053/j.gastro.2008.06.033] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
278 Lleonart ME, Ramón y Cajal S, Groopman JD, Friesen MD. Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis. Nucleic Acids Res 2004;32:e53. [PMID: 15037663 DOI: 10.1093/nar/gnh051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
279 Chave HS, Gough AC, Palmer K, Preston SR, Primrose JN. Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer. 2000;82:124-130. [PMID: 10638978 DOI: 10.1054/bjoc.1998.0888] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
280 Taieb J, Le Malicot K, Shi Q, Penault-Llorca F, Bouché O, Tabernero J, Mini E, Goldberg RM, Folprecht G, Luc Van Laethem J, Sargent DJ, Alberts SR, Emile JF, Laurent Puig P, Sinicrope FA. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer. J Natl Cancer Inst 2017;109. [PMID: 28040692 DOI: 10.1093/jnci/djw272] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 20.4] [Reference Citation Analysis]
281 Bruin SC, He Y, Mikolajewska-Hanclich I, Liefers GJ, Klijn C, Vincent A, Verwaal VJ, de Groot KA, Morreau H, van Velthuysen ML, Tollenaar RA, van 't Veer LJ. Molecular alterations associated with liver metastases development in colorectal cancer patients. Br J Cancer 2011;105:281-7. [PMID: 21673680 DOI: 10.1038/bjc.2011.184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
282 Haier J, Nasralla M, Nicolson GL. Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 2000;231:11-24. [PMID: 10636097 DOI: 10.1097/00000658-200001000-00003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
283 Rameshshanker R, Wilson A. Electronic Imaging in Colonoscopy: Clinical Applications and Future Prospects. Curr Treat Options Gastroenterol. 2016;14:140-151. [PMID: 26923476 DOI: 10.1007/s11938-016-0075-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
284 Sullivan KM, Kozuch PS. Impact of KRAS Mutations on Management of Colorectal Carcinoma. Patholog Res Int. 2011;2011:219309. [PMID: 21437184 DOI: 10.4061/2011/219309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
285 Ngo NT, Tan E, Tekkis P, Peston D, Cohen P. Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. Int J Colorectal Dis 2010;25:1193-200. [PMID: 20640432 DOI: 10.1007/s00384-010-1007-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
286 McGillen JB, Gaffney EA, Martin NK, Maini PK. A general reaction-diffusion model of acidity in cancer invasion. J Math Biol 2014;68:1199-224. [PMID: 23536240 DOI: 10.1007/s00285-013-0665-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
287 Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T. Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol 2011;178:1478-88. [PMID: 21435437 DOI: 10.1016/j.ajpath.2010.12.036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
288 Maitra A, Molberg K, Albores-Saavedra J, Lindberg G. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol. 2000;157:1105-1111. [PMID: 11021814 DOI: 10.1016/S0002-9440(10)64625-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
289 Gurunathan S, Qasim M, Kang MH, Kim JH. Role and Therapeutic Potential of Melatonin in Various Type of Cancers. Onco Targets Ther 2021;14:2019-52. [PMID: 33776451 DOI: 10.2147/OTT.S298512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
290 Spit M, Koo BK, Maurice MM. Tales from the crypt: intestinal niche signals in tissue renewal, plasticity and cancer. Open Biol 2018;8:180120. [PMID: 30209039 DOI: 10.1098/rsob.180120] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 15.7] [Reference Citation Analysis]
291 Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, van Noesel CJ. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol 2011;178:2700-7. [PMID: 21641392 DOI: 10.1016/j.ajpath.2011.02.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
292 Skalnik DG, Dorfman DM, Williams DA, Orkin SH. Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol Cell Biol 1991;11:4518-27. [PMID: 1652058 DOI: 10.1128/mcb.11.9.4518-4527.1991] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
293 Bowman EA, Pfau PR, Mitra A, Reichelderfer M, Gopal DV, Hall BS, Benson ME. High Definition Colonoscopy Combined with i-SCAN Imaging Technology Is Superior in the Detection of Adenomas and Advanced Lesions Compared to High Definition Colonoscopy Alone. Diagn Ther Endosc 2015;2015:167406. [PMID: 26167108 DOI: 10.1155/2015/167406] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
294 Nishimura M, Naka S, Hanazawa K, Tani T, Fukami M, Okada S, Fujiyama Y. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis. Dig Dis Sci. 2005;50:2153-2158. [PMID: 16240231 DOI: 10.1007/s10620-005-3023-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
295 Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, Meltzer SJ, Wright C, Searle J, Young J, Leggett BA. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-60. [PMID: 10562815 DOI: 10.1136/jcp.52.6.455] [Cited by in Crossref: 146] [Cited by in F6Publishing: 147] [Article Influence: 6.6] [Reference Citation Analysis]
296 Randhawa H, Kibble K, Zeng H, Moyer MP, Reindl KM. Activation of ERK signaling and induction of colon cancer cell death by piperlongumine. Toxicol In Vitro 2013;27:1626-33. [PMID: 23603476 DOI: 10.1016/j.tiv.2013.04.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
297 Otto C, Schmidt S, Kastner C, Denk S, Kettler J, Müller N, Germer CT, Wolf E, Gallant P, Wiegering A. Targeting bromodomain-containing protein 4 (BRD4) inhibits MYC expression in colorectal cancer cells. Neoplasia 2019;21:1110-20. [PMID: 31734632 DOI: 10.1016/j.neo.2019.10.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
298 Ohnami S, Maruyama K, Chen K, Takahashi Y, Hatakeyama K, Ohshima K, Shimoda Y, Sakai A, Kamada F, Nakatani S, Naruoka A, Ohnami S, Kusuhara M, Akiyama Y, Kagawa H, Shiomi A, Nagashima T, Urakami K, Yamaguchi K. BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer. Mol Cell Biochem 2021;476:3469-82. [PMID: 33982211 DOI: 10.1007/s11010-021-04172-8] [Reference Citation Analysis]
299 Dong F, Budhu AS, Wang XW. Translating the metastasis paradigm from scientific theory to clinical oncology. Clin Cancer Res 2009;15:2588-93. [PMID: 19351761 DOI: 10.1158/1078-0432.CCR-08-2356] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
300 Chang PY, Chen JS, Chang SC, Wang MC, Chang NC, Wen YH, Tsai WS, Liu WH, Liu HL, Lu JJ. Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer. Oncotarget 2017;8:72352-62. [PMID: 29069792 DOI: 10.18632/oncotarget.20376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
301 Goodman M, LaKind JS, Fagliano JA, Lash TL, Wiemels JL, Winn DM, Patel C, Van Eenwyk J, Kohler BA, Schisterman EF, Albert P, Mattison DR. Cancer cluster investigations: review of the past and proposals for the future. Int J Environ Res Public Health 2014;11:1479-99. [PMID: 24477211 DOI: 10.3390/ijerph110201479] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
302 Brandl L, Kirstein N, Neumann J, Sendelhofert A, Vieth M, Kirchner T, Menssen A. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target. Med Oncol 2018;36:5. [PMID: 30460421 DOI: 10.1007/s12032-018-1225-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
303 Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89-103. [PMID: 31616522 DOI: 10.5114/pg.2018.81072] [Cited by in Crossref: 190] [Cited by in F6Publishing: 186] [Article Influence: 95.0] [Reference Citation Analysis]
304 Lonardo F, Guan H, Dzinic S, Sheng S. Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma. Histopathology 2014;65:757-63. [PMID: 25040445 DOI: 10.1111/his.12485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
305 Shin JS, Tut TG, Yang T, Lee CS. Radiotherapy response in microsatellite instability related rectal cancer. Korean J Pathol 2013;47:1-8. [PMID: 23482947 DOI: 10.4132/KoreanJPathol.2013.47.1.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
306 Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O'Brien M, Ogino S. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol 2014;109:1205-14. [PMID: 24935274 DOI: 10.1038/ajg.2014.153] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
307 Li FP. Molecular epidemiology studies of cancer in families. Br J Cancer 1993;68:217-9. [PMID: 8347474 DOI: 10.1038/bjc.1993.318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
308 Lee J, Fricke F, Warnken U, Schnölzer M, Kopitz J, Gebert J. Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells. PLoS One 2015;10:e0131506. [PMID: 26114631 DOI: 10.1371/journal.pone.0131506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
309 Deming DA, Leystra AA, Farhoud M, Nettekoven L, Clipson L, Albrecht D, Washington MK, Sullivan R, Weichert JP, Halberg RB. mTOR inhibition elicits a dramatic response in PI3K-dependent colon cancers. PLoS One 2013;8:e60709. [PMID: 23593290 DOI: 10.1371/journal.pone.0060709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
310 Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res 2014;12:194-204. [PMID: 25349593 DOI: 10.5217/ir.2014.12.3.194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
311 Garnis C, Buys TP, Lam WL. Genetic alteration and gene expression modulation during cancer progression. Mol Cancer 2004;3:9. [PMID: 15035667 DOI: 10.1186/1476-4598-3-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
312 Nguyen HT, Duong HQ. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (review). Oncol Lett. 2018;16:9-18. [PMID: 29928381 DOI: 10.3892/ol.2018.8679] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
313 Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci U S A 1998;95:2950-5. [PMID: 9501196 DOI: 10.1073/pnas.95.6.2950] [Cited by in Crossref: 344] [Cited by in F6Publishing: 307] [Article Influence: 15.0] [Reference Citation Analysis]
314 Haupt S, Zeilmann A, Ahadova A, Bläker H, von Knebel Doeberitz M, Kloor M, Heuveline V. Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure. PLoS Comput Biol 2021;17:e1008970. [PMID: 34003820 DOI: 10.1371/journal.pcbi.1008970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Kim ST, Park KH, Kim JS, Shin SW, Kim YH. Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy. Cancer Res Treat. 2013;45:55-62. [PMID: 23613671 DOI: 10.4143/crt.2013.45.1.55] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
316 Organ SL, Hai J, Radulovich N, Marshall CB, Leung L, Sasazuki T, Shirasawa S, Zhu CQ, Navab R, Ikura M, Tsao MS. p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line. PLoS One 2014;9:e86103. [PMID: 24465899 DOI: 10.1371/journal.pone.0086103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
317 Lamberti C, Lundin S, Bogdanow M, Pagenstecher C, Friedrichs N, Büttner R, Sauerbruch T. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis 2007;22:145-52. [PMID: 16724208 DOI: 10.1007/s00384-006-0131-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
318 Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H. Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review. Oncologist. 2011;16:1239-1249. [PMID: 21742964 DOI: 10.1634/theoncologist.2011-0024] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
319 Lee W, Belkhiri A, Lockhart AC, Merchant N, Glaeser H, Harris EI, Washington MK, Brunt EM, Zaika A, Kim RB, El-Rifai W. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res 2008;68:10315-23. [PMID: 19074900 DOI: 10.1158/0008-5472.CAN-08-1984] [Cited by in Crossref: 91] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
320 Shin E, Fujita S, Takami K, Kurahashi H, Kurita Y, Kobayashi T, Mori T, Nishisho I, Takai S. Deletion Mapping of Chromosome 1p and 22q in Pheochromocytoma. Japanese Journal of Cancer Research 1993;84:402-8. [DOI: 10.1111/j.1349-7006.1993.tb00150.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
321 Jun YJ, Jang SM, Han HL, Lee KH, Jang KS, Paik SS. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 2011;17:1866-73. [PMID: 21528061 DOI: 10.3748/wjg.v17.i14.1866] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
322 Stephenson BM, Murday VA, Finan PJ, Quirke P, Dixon MF, Bishop DT. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 1993;34:96-100. [PMID: 8432460 DOI: 10.1136/gut.34.1.96] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
323 Ozery-Flato M, Linhart C, Trakhtenbrot L, Izraeli S, Shamir R. Large-scale analysis of chromosomal aberrations in cancer karyotypes reveals two distinct paths to aneuploidy. Genome Biol 2011;12:R61. [PMID: 21714908 DOI: 10.1186/gb-2011-12-6-r61] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
324 Mueller S, Dennison G, Liu S. An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality. Int J Environ Res Public Health 2021;18:6930. [PMID: 34203568 DOI: 10.3390/ijerph18136930] [Reference Citation Analysis]
325 Dou Y, Cha DJ, Franklin JL, Higginbotham JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG, Zhang B. Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes. Sci Rep 2016;6:37982. [PMID: 27892494 DOI: 10.1038/srep37982] [Cited by in Crossref: 160] [Cited by in F6Publishing: 158] [Article Influence: 32.0] [Reference Citation Analysis]
326 Seol JE, Cho CH, Kim SH, Lee JE. Total and Dietary Calcium Intake and Colorectal Adenoma in Korean Adults. J Cancer Prev 2015;20:153-8. [PMID: 26151049 DOI: 10.15430/JCP.2015.20.2.153] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
327 Yang T, Owen JL, Lightfoot YL, Kladde MP, Mohamadzadeh M. Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med 2013;19:714-25. [PMID: 24051204 DOI: 10.1016/j.molmed.2013.08.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
328 Zhao Y, Wu TY, Zhao MF, Li CJ. The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease. J Biol Chem 2020;295:5152-62. [PMID: 32139507 DOI: 10.1074/jbc.REV119.008897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
329 Tubin S, Khan MK, Gupta S, Jeremic B. Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment. Cancers (Basel) 2021;13:775. [PMID: 33673332 DOI: 10.3390/cancers13040775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
330 Norheim Andersen S, Breivik J, Løvig T, Meling GI, Gaudernack G, Clausen OP, Schjölberg A, Fausa O, Langmark F, Lund E. K-ras mutations and HLA-DR expression in large bowel adenomas. Br J Cancer. 1996;74:99-108. [PMID: 8679466 DOI: 10.1038/bjc.1996.322] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
331 Nalejska E, Mączyńska E, Lewandowska MA. Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther 2014;18:273-84. [PMID: 24385403 DOI: 10.1007/s40291-013-0077-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 13.3] [Reference Citation Analysis]
332 Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010;15:390-404. [PMID: 20350999 DOI: 10.1634/theoncologist.2009-0233] [Cited by in Crossref: 115] [Cited by in F6Publishing: 96] [Article Influence: 10.5] [Reference Citation Analysis]
333 Zhao Y, Chen ZX, Rewuti A, Ma YS, Wang XF, Xia Q, Fu D, Han YS. quantitative assessment of the influence of cytochrome P450 1A2 gene polymorphism and colorectal cancer risk. PLoS One 2013;8:e71481. [PMID: 23951174 DOI: 10.1371/journal.pone.0071481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
334 East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66:1181-1196. [PMID: 28450390 DOI: 10.1136/gutjnl-2017-314005] [Cited by in Crossref: 130] [Cited by in F6Publishing: 90] [Article Influence: 32.5] [Reference Citation Analysis]
335 Curran B, Lenehan K, Mulcahy H, Tighe O, Bennett MA, Kay EW, O'Donoghue DP, Leader M, Croke DT. Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer. Gut. 2000;46:200-204. [PMID: 10644313 DOI: 10.1136/gut.46.2.200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
336 Fox JC, England J, White P, Ellison G, Callaghan K, Charlesworth NR, Hehir J, McCarthy TL, Smith-Ravin J, Talbot IC, Snary D, Northover JM, Newton CR, Little S. The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. Br J Cancer 1998;77:1267-74. [PMID: 9579832 DOI: 10.1038/bjc.1998.212] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
337 Sharaiha RZ, Cohen MS, Reimers L, Khashab MA, Giardiello FM, Neugut AI. Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study. Dig Dis Sci. 2014;59:2523-2528. [PMID: 24821462 DOI: 10.1007/s10620-014-3188-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
338 Monticone M, Biollo E, Maffei M, Donadini A, Romeo F, Storlazzi CT, Giaretti W, Castagnola P. Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context. Mol Cancer 2008;7:92. [PMID: 19087308 DOI: 10.1186/1476-4598-7-92] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
339 Meltzer SJ, Yin J, Huang Y, McDaniel TK, Newkirk C, Iseri O, Vogelstein B, Resau JH. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci U S A 1991;88:4976-80. [PMID: 2052580 DOI: 10.1073/pnas.88.11.4976] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 2.6] [Reference Citation Analysis]
340 Fan F, Schimming A, Jaeger D, Podar K. Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012;2012:281261. [PMID: 21876693 DOI: 10.1155/2012/281261] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
341 Mamot C, Mild G, Reuter J, Laffer U, Metzger U, Terracciano L, Boulay JL, Herrmann R, Rochlitz C. Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer. Br J Cancer. 2003;88:420-423. [PMID: 12569386 DOI: 10.1038/sj.bjc.6600733] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
342 Benachenhou N, Guiral S, Gorska-Flipot I, Labuda D, Sinnett D. Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer. Br J Cancer. 1999;79:1012-1017. [PMID: 10098729 DOI: 10.1038/sj.bjc.6690162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
343 Wang W, Wang GQ, Sun XW, Chen G, Li YF, Zhang LY, Qiu HB, Huang CY, Zhan YQ, Zhou ZW. Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma. World J Gastroenterol. 2010;16:6026-6034. [PMID: 21157981 DOI: 10.3748/wjg.v16.i47.6026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
344 Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008;10:13-27. [PMID: 18165277 DOI: 10.2353/jmoldx.2008.070082] [Cited by in Crossref: 289] [Cited by in F6Publishing: 259] [Article Influence: 20.6] [Reference Citation Analysis]
345 Andersen SN, Lovig T, Clausen OP, Bakka A, Fausa O, Rognum TO. Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut. 1999;45:686-692. [PMID: 10517904 DOI: 10.1136/gut.45.5.686] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
346 Park DY, Sakamoto H, Kirley SD, Ogino S, Kawasaki T, Kwon E, Mino-Kenudson M, Lauwers GY, Chung DC, Rueda BR, Zukerberg LR. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol 2007;171:1509-19. [PMID: 17982127 DOI: 10.2353/ajpath.2007.070331] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
347 Buyru N, Tezol A, Dalay N. Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 2006;6:115. [PMID: 16672071 DOI: 10.1186/1471-2407-6-115] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
348 Ogawa Y, Kudo SE, Mori Y, Ikehara N, Maeda Y, Wakamura K, Misawa M, Kudo T, Hayashi T, Miyachi H, Katagiri A, Ishida F, Inoue H. Use of endocytoscopy for identification of sessile serrated adenoma/polyps and hyperplastic polyps by quantitative image analysis of the luminal areas. Endosc Int Open 2017;5:E769-74. [PMID: 28791327 DOI: 10.1055/s-0043-113562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
349 Kumaradevan S, Lee SY, Richards S, Lyle C, Zhao Q, Tapan U, Jiangliu Y, Ghumman S, Walker J, Belghasem M, Arinze N, Kuhnen A, Weinberg J, Francis J, Hartshorn K, Kolachalama VB, Cifuentes D, Rahimi N, Chitalia VC. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation. Am J Pathol 2018;188:1921-33. [PMID: 30029779 DOI: 10.1016/j.ajpath.2018.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
350 Fernández-Cebrián JM, Nevado Santos M, Vorwald Kuborn P, Pardo de Lama M, Martín-Cavanna J, Pacheco Martínez P, Fernández Escudero B, Ramos Fernández M. Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression? Clin Transl Oncol 2007;9:663-70. [PMID: 17974527 DOI: 10.1007/s12094-007-0119-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
351 Patel VB, Misra S, Patel BB, Majumdar AP. Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer. 2010;62:958-967. [PMID: 20924971 DOI: 10.1080/01635581.2010.510259] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
352 Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC. Gastrin is a target of the beta-catenin/TCF-4 growth- signaling pathway in a model of intestinal polyposis. J Clin Invest. 2000;106:533-539. [PMID: 10953028 DOI: 10.1172/JCI9476] [Cited by in Crossref: 132] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
353 Mori G, Rampelli S, Orena BS, Rengucci C, De Maio G, Barbieri G, Passardi A, Casadei Gardini A, Frassineti GL, Gaiarsa S, Albertini AM, Ranzani GN, Calistri D, Pasca MR. Shifts of Faecal Microbiota During Sporadic Colorectal Carcinogenesis. Sci Rep. 2018;8:10329. [PMID: 29985435 DOI: 10.1038/s41598-018-28671-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
354 Jin X, Che DB, Zhang ZH, Yan HM, Jia ZY, Jia XB. Ginseng consumption and risk of cancer: A meta-analysis. J Ginseng Res 2016;40:269-77. [PMID: 27616903 DOI: 10.1016/j.jgr.2015.08.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
355 Doubeni CA, Selby K, Gupta S. Framework and Strategies to Eliminate Disparities in Colorectal Cancer Screening Outcomes. Annu Rev Med 2021;72:383-98. [PMID: 33208026 DOI: 10.1146/annurev-med-051619-035840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
356 Nik-Zainal S, Hall BA. Cellular survival over genomic perfection. Science 2019;366:802-3. [PMID: 31727818 DOI: 10.1126/science.aax8046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
357 Flugelman AA, Stein N, Segol O, Lavi I, Keinan-Boker L. Delayed Colonoscopy Following a Positive Fecal Test Result and Cancer Mortality. JNCI Cancer Spectr 2019;3:pkz024. [PMID: 31360901 DOI: 10.1093/jncics/pkz024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
358 Han SW, Ahn JY, Lee S, Noh YS, Jung HC, Lee MH, Park HJ, Chun HJ, Choi SJ, Kim ES, Lee JY. Gene expression network analysis of lymph node involvement in colon cancer identifies AHSA2, CDK10, and CWC22 as possible prognostic markers. Sci Rep 2020;10:7170. [PMID: 32345988 DOI: 10.1038/s41598-020-63806-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
359 Yang Y, Wang F, Shi C, Zou Y, Qin H, Ma Y. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies. PLoS One 2012;7:e36813. [PMID: 22606291 DOI: 10.1371/journal.pone.0036813] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
360 Nakayama Y, Iijima T, Wakaume R, Takahashi K, Matsumoto H, Nakano D, Miyaki M, Yamaguchi T. Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer. PLoS One 2019;14:e0215513. [PMID: 31002690 DOI: 10.1371/journal.pone.0215513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
361 Martínez F, Fernández-Martos C, Quintana MJ, Castells A, Llombart A, Ińiguez F, Guillem V, Dasí F. APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study. Clin Transl Oncol 2011;13:664-71. [PMID: 21865138 DOI: 10.1007/s12094-011-0712-z] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
362 Ding SF, Habib NA, Dooley J, Wood C, Bowles L, Delhanty JD. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 1991;64:1083-7. [PMID: 1684907 DOI: 10.1038/bjc.1991.468] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 1.6] [Reference Citation Analysis]
363 Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer. 2008;8:255. [PMID: 18782444 DOI: 10.1186/1471-2407-8-255] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
364 Muthu M, Chun S, Gopal J, Park GS, Nile A, Shin J, Shin J, Kim TH, Oh JW. The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy? Int J Mol Sci 2020;21:E5583. [PMID: 32759789 DOI: 10.3390/ijms21155583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Hatakeyama K, Ohshima K, Nagashima T, Ohnami S, Ohnami S, Serizawa M, Shimoda Y, Maruyama K, Akiyama Y, Urakami K, Kusuhara M, Mochizuki T, Yamaguchi K. Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations. Sci Rep 2018;8:8700. [PMID: 29880869 DOI: 10.1038/s41598-018-26967-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
366 Haugen A, Maehle L, Mollerup S, Rivedal E, Ryberg D. Nickel-induced alterations in human renal epithelial cells. Environ Health Perspect 1994;102 Suppl 3:117-8. [PMID: 7843084 DOI: 10.1289/ehp.94102s3117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
367 Ward R, Hawkins N, O'Grady R, Sheehan C, O'Connor T, Impey H, Roberts N, Fuery C, Todd A. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am J Pathol 1998;153:373-9. [PMID: 9708798 DOI: 10.1016/S0002-9440(10)65581-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
368 Tanaka T, Watanabe T, Kazama Y, Tanaka J, Kanazawa T, Kazama S, Nagawa H. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification. Br J Cancer. 2006;95:1562-1567. [PMID: 17088901 DOI: 10.1038/sj.bjc.6603460] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
369 Grizzi F, Celesti G, Basso G, Laghi L. Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope? World J Gastroenterol. 2012;18:6532-6536. [PMID: 23236225 DOI: 10.3748/wjg.v18.i45.6532] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
370 Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, Jarosz D, Pachlewski J, Oledzki J, Ostrowski J. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One. 2010;5. [PMID: 20957034 DOI: 10.1371/journal.pone.0013091] [Cited by in Crossref: 160] [Cited by in F6Publishing: 208] [Article Influence: 14.5] [Reference Citation Analysis]
371 Ooki A, Akagi K, Yatsuoka T, Asayama M, Hara H, Nishimura Y, Katoh H, Yamashita K, Watanabe M, Yamaguchi K. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer. J Gastrointest Surg 2017;21:867-78. [PMID: 28251467 DOI: 10.1007/s11605-017-3382-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
372 Villaseca MA, Roa I, Araya JC, Roa JC, Flores P. Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol Pathol 1997;50:317-21. [PMID: 9536282 DOI: 10.1136/mp.50.6.317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
373 Il Lee S, Zuo X, Shureiqi I. 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? Cancer Metastasis Rev 2011;30:481-91. [PMID: 22037943 DOI: 10.1007/s10555-011-9321-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
374 Yoshida N, Naito Y, Yasuda R, Murakami T, Hirose R, Ogiso K, Inada Y, Dohi O, Kamada K, Uchiyama K, Handa O, Konishi H, Rani RA, Kishimoto M, Konishi E, Itoh Y. Linked color imaging improves the visibility of various featured colorectal polyps in an endoscopist's visibility and color difference value. Int J Colorectal Dis 2017;32:1253-60. [PMID: 28725959 DOI: 10.1007/s00384-017-2855-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
375 Jass JR. Origins of ... familial cancer: histopathological perspectives. J Clin Pathol 1997;50:892-5. [PMID: 9462236 DOI: 10.1136/jcp.50.11.892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
376 Repass J, Maherali N, Owen K; Reproducibility Project: Cancer Biology., Reproducibility Project Cancer Biology. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Elife 2016;5:e10012. [PMID: 26882501 DOI: 10.7554/eLife.10012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
377 Winder T, Lenz HJ. Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist. 2010;15:836-844. [PMID: 20656916 DOI: 10.1634/theoncologist.2010-0052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
378 You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci U S A 1989;86:3070-4. [PMID: 2654935 DOI: 10.1073/pnas.86.9.3070] [Cited by in Crossref: 224] [Cited by in F6Publishing: 187] [Article Influence: 7.0] [Reference Citation Analysis]
379 Yoshii S, Hayashi Y, Iijima H, Inoue T, Kimura K, Sakatani A, Nagai K, Fujinaga T, Hiyama S, Kodama T, Shinzaki S, Tsujii Y, Watabe K, Takehara T. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression. Cancer Sci 2019;110:2396-407. [PMID: 31148360 DOI: 10.1111/cas.14084] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
380 Dulskas A, Samalavicius NE, Gupta RK, Zabulis V. Laparoscopic colorectal surgery for colorectal polyps: single institution experience. Wideochir Inne Tech Maloinwazyjne. 2015;10:73-78. [PMID: 25960797 DOI: 10.5114/wiitm.2015.49752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
381 Mehrabi S, Akwe JA, Adams G Jr, Grizzle W, Yao X, Aikhionbare FO. Analysis of mtDNA sequence variants in colorectal adenomatous polyps. Diagn Pathol 2010;5:66. [PMID: 20929553 DOI: 10.1186/1746-1596-5-66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
382 AbouAitah K, Hassan HA, Swiderska-Sroda A, Gohar L, Shaker OG, Wojnarowicz J, Opalinska A, Smalc-Koziorowska J, Gierlotka S, Lojkowski W. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. Cancers (Basel) 2020;12:E144. [PMID: 31936103 DOI: 10.3390/cancers12010144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
383 Tanaka T, Kobunai T, Yamamoto Y, Emoto S, Murono K, Kaneko M, Sasaki K, Otani K, Nishikawa T, Kawai K, Hata K, Nozawa H, Watanabe T. Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step. Cancer Genomics Proteomics 2017;14:341-8. [PMID: 28871001 DOI: 10.21873/cgp.20044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
384 Liu J, Chang KW, Yao J, Summers RM. Predicting polyp location on optical colonoscopy from CT colonography by minimal-energy curve modeling of the colonoscope path. IEEE Trans Biomed Eng 2012;59:3531-40. [PMID: 23033425 DOI: 10.1109/TBME.2012.2217960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
385 Chiang AC, Massagué J. Molecular basis of metastasis. N Engl J Med. 2008;359:2814-2823. [PMID: 19109576 DOI: 10.1056/nejmra0805239] [Cited by in Crossref: 671] [Cited by in F6Publishing: 330] [Article Influence: 55.9] [Reference Citation Analysis]
386 Pyo JH, Kim ES, Chun HJ, Keum B, Jeen YT, Lee HS, Kim CD, Ryu HS, Kim YH, Lee JE. Fasting blood sugar and serum triglyceride as the risk factors of colorectal adenoma in korean population receiving screening colonoscopy. Clin Nutr Res 2013;2:34-41. [PMID: 23429421 DOI: 10.7762/cnr.2013.2.1.34] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
387 de Bono JS, Tolcher AW, Rowinsky EK. The future of cytotoxic therapy: selective cytotoxicity based on biology is the key. Breast Cancer Res 2003;5:154-9. [PMID: 12793897 DOI: 10.1186/bcr597] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
388 Kuroda A, Tsukamoto Y, Nguyen LT, Noguchi T, Takeuchi I, Uchida M, Uchida T, Hijiya N, Nakada C, Okimoto T, Kodama M, Murakami K, Matsuura K, Seto M, Ito H, Fujioka T, Moriyama M. Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization. PLoS One 2011;6:e22313. [PMID: 21811585 DOI: 10.1371/journal.pone.0022313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
389 Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A 2006;103:18238-42. [PMID: 17108085 DOI: 10.1073/pnas.0607057103] [Cited by in Crossref: 255] [Cited by in F6Publishing: 208] [Article Influence: 17.0] [Reference Citation Analysis]
390 McCarthy AJ, Serra S, Chetty R. Traditional serrated adenoma: an overview of pathology and emphasis on molecular pathogenesis. BMJ Open Gastroenterol. 2019;6:e000317. [PMID: 31413858 DOI: 10.1136/bmjgast-2019-000317] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
391 Marks AR, Pietrofesa RA, Jensen CD, Zebrowski A, Corley DA, Doubeni CA. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2015;24:1692-1698. [PMID: 26377195 DOI: 10.1158/1055-9965.epi-15-0559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
392 Waldmann E, Britto-Arias M, Gessl I, Heinze G, Salzl P, Sallinger D, Trauner M, Weiss W, Ferlitsch A, Ferlitsch M. Endoscopists with low adenoma detection rates benefit from high-definition endoscopy. Surg Endosc 2015;29:466-73. [PMID: 25005016 DOI: 10.1007/s00464-014-3688-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
393 Isoda T, Nakatsu Y, Yamauchi K, Piao J, Yao T, Honda H, Nakabeppu Y, Tsuzuki T. Abnormality in Wnt signaling is causatively associated with oxidative stress-induced intestinal tumorigenesis in MUTYH-null mice. Int J Biol Sci 2014;10:940-7. [PMID: 25170306 DOI: 10.7150/ijbs.9241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
394 Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006;55:695-702. [PMID: 16354798 DOI: 10.1136/gut.2005.079459] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
395 Baxter E, Windloch K, Gannon F, Lee JS. Epigenetic regulation in cancer progression. Cell Biosci 2014;4:45. [PMID: 25949794 DOI: 10.1186/2045-3701-4-45] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
396 Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol. 1999;154:515-523. [PMID: 10027409 DOI: 10.1016/s0002-9440(10)65297-2] [Cited by in Crossref: 353] [Cited by in F6Publishing: 193] [Article Influence: 16.0] [Reference Citation Analysis]
397 Peltomäki P, Alfthan O, de la Chapelle A. Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer 1991;63:851-8. [PMID: 1829952 DOI: 10.1038/bjc.1991.189] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
398 Markowitz SD, Myeroff L, Cooper MJ, Traicoff J, Kochera M, Lutterbaugh J, Swiriduk M, Willson JK. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J Clin Invest 1994;93:1005-13. [PMID: 8132740 DOI: 10.1172/JCI117048] [Cited by in Crossref: 49] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
399 Dunn GP, Rinne ML, Wykosky J, Genovese G, Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, Brennan C, Ligon KL, Furnari F, Cavenee WK, Depinho RA, Chin L, Hahn WC. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 2012;26:756-84. [PMID: 22508724 DOI: 10.1101/gad.187922.112] [Cited by in Crossref: 345] [Cited by in F6Publishing: 316] [Article Influence: 38.3] [Reference Citation Analysis]
400 Chadla P, Arbi M, Nikou S, Kalliakoudas T, Papadaki H, Taraviras S, Lygerou Z, Bravou V. Integrin-Linked-Kinase Overexpression Is Implicated in Mechanisms of Genomic Instability in Human Colorectal Cancer. Dig Dis Sci 2021;66:1510-23. [PMID: 32495257 DOI: 10.1007/s10620-020-06364-6] [Reference Citation Analysis]
401 Rappa F, Pitruzzella A, Marino Gammazza A, Barone R, Mocciaro E, Tomasello G, Carini F, Farina F, Zummo G, Conway de Macario E, Macario AJ, Cappello F. Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer. Cell Stress Chaperones 2016;21:927-33. [PMID: 27491302 DOI: 10.1007/s12192-016-0721-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
402 Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017;17:79-92. [PMID: 28050011 DOI: 10.1038/nrc.2016.126] [Cited by in Crossref: 338] [Cited by in F6Publishing: 263] [Article Influence: 84.5] [Reference Citation Analysis]
403 Nakagami K, Uchida T, Ohwada S, Koibuchi Y, Suda Y, Sekine T, Morishita Y. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res 1999;90:419-24. [PMID: 10363580 DOI: 10.1111/j.1349-7006.1999.tb00764.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 3.8] [Reference Citation Analysis]
404 Nanashima A, Yamaguchi H, Yasutake T, Sawai T, Kusano H, Tagawa Y, Nakagoe T, Ayabe H. Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers. Dig Dis Sci. 1997;42:1388-1393. [PMID: 9246034 DOI: 10.1023/a:1018885803931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
405 Tanaka T, Ichikawa K, Maruoka T, Tomita S, Ueda H, Yamaguchi T, Shida Y, Kato H, Nagata H, Kubota K, Akimoto N, Sakamoto C, Imura J, Arita M, Tanaka H, Okamoto Y, Igarashi Y, Fujimori T. Analysis of the anatomic subsites, gender and age in unresectable advanced colorectal carcinomas in Tochigi, Japan suggests a shift in location towards the right side colon in elderly patients treated with cetuximab. Mol Clin Oncol 2013;1:291-6. [PMID: 24649163 DOI: 10.3892/mco.2013.62] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
406 Veschi S, Lattanzio R, Aceto GM, Curia MC, Magnasco S, Angelucci D, Cama A, Piantelli M, Battista P. Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids. Int J Oncol. 2012;41:1221-1228. [PMID: 22825745 DOI: 10.3892/ijo.2012.1563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
407 Nakanishi R, Shimizu T, Kumagai K, Takai A, Marusawa H. Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs. Pathogens 2021;10:453. [PMID: 33918902 DOI: 10.3390/pathogens10040453] [Reference Citation Analysis]
408 Alharbi A, Bin Dokhi H, Almuhaini G, Alomran F, Masuadi E, Alomran N. Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia. PLoS One 2021;16:e0249590. [PMID: 33979337 DOI: 10.1371/journal.pone.0249590] [Reference Citation Analysis]
409 Endo T, Ookawa K, Tanaka M, Nakaji S, Tsuchida S, Sugawara K. Differences in carcinogenesis by the length of carcinogen exposure period in rat colon. Dig Dis Sci 2001;46:109-17. [PMID: 11270774 DOI: 10.1023/a:1005613926089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
410 Chu PC, Lin PC, Wu HY, Lin KT, Wu C, Bekaii-Saab T, Lin YJ, Lee CT, Lee JC, Chen CS. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Oncogene 2018;37:3440-55. [PMID: 29559746 DOI: 10.1038/s41388-018-0222-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
411 Kojima Y, Ohtsuka K, Ohnishi H, Abe N, Furuse J, Watanabe T, Sugiyama M. APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas. Surg Today 2018;48:765-72. [PMID: 29525853 DOI: 10.1007/s00595-018-1649-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
412 Grand RJ, Owen D. The biochemistry of ras p21. Biochem J 1991;279 ( Pt 3):609-31. [PMID: 1953656 DOI: 10.1042/bj2790609] [Cited by in Crossref: 128] [Cited by in F6Publishing: 108] [Article Influence: 4.3] [Reference Citation Analysis]
413 Nakazawa K, Nouda S, Kakimoto K, Kinoshita N, Tanaka Y, Tawa H, Koshiba R, Naka Y, Hirata Y, Ota K, Kawakami K, Takeuchi T, Inoue T, Miyazaki T, Sanomura M, Nakamura S, Saito Y, Higuchi K. The Differential Diagnosis of Colorectal Polyps Using Colon Capsule Endoscopy. Intern Med 2021;60:1805-12. [PMID: 33456043 DOI: 10.2169/internalmedicine.6446-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
414 Smith ME, Marsh SG, Bodmer JG, Gelsthorpe K, Bodmer WF. Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci U S A 1989;86:5557-61. [PMID: 2473473 DOI: 10.1073/pnas.86.14.5557] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 2.6] [Reference Citation Analysis]
415 Hara A, Hibi T, Yoshioka M, Toda K, Watanabe N, Hayashi A, Iwao Y, Saito H, Watanabe T, Tsuchiya M. Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line. Jpn J Cancer Res 1993;84:625-32. [PMID: 8393433 DOI: 10.1111/j.1349-7006.1993.tb02022.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
416 Guarini C, Grassi T, Pezzicoli G, Porta C. Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer. Int J Mol Sci 2021;22:6813. [PMID: 34202896 DOI: 10.3390/ijms22136813] [Reference Citation Analysis]
417 Nandan MO, McConnell BB, Ghaleb AM, Bialkowska AB, Sheng H, Shao J, Babbin BA, Robine S, Yang VW. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 2008;134:120-30. [PMID: 18054006 DOI: 10.1053/j.gastro.2007.10.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 6.6] [Reference Citation Analysis]
418 Gallmeier E, Gress TM. [Pancreatic ductal adenocarcinoma]. Internist (Berl). 2018;59:805-822. [PMID: 29980819 DOI: 10.1007/s00108-018-0460-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
419 Reiter JG, Makohon-Moore AP, Gerold JM, Bozic I, Chatterjee K, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA. Reconstructing metastatic seeding patterns of human cancers. Nat Commun 2017;8:14114. [PMID: 28139641 DOI: 10.1038/ncomms14114] [Cited by in Crossref: 73] [Cited by in F6Publishing: 53] [Article Influence: 18.3] [Reference Citation Analysis]
420 Kim DH, Ahn YO. Molecular epidemiology of colon cancer. Cancer Res Treat 2004;36:93-9. [PMID: 20396547 DOI: 10.4143/crt.2004.36.2.93] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
421 Randrian V, Evrard C, Tougeron D. Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies. Cancers (Basel) 2021;13:3063. [PMID: 34205397 DOI: 10.3390/cancers13123063] [Reference Citation Analysis]
422 Silverman GA, Ye RD, Pollock KM, Sadler JE, Korsmeyer SJ. Use of yeast artificial chromosome clones for mapping and walking within human chromosome segment 18q21.3. Proc Natl Acad Sci U S A 1989;86:7485-9. [PMID: 2678105 DOI: 10.1073/pnas.86.19.7485] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 1.3] [Reference Citation Analysis]
423 Konstantinova LN, Fleischman EW, Knisch VI, Perevozchikov AG, Kopnin BP. Karyotype peculiarities of human colorectal adenocarcinomas. Hum Genet 1991;86:491-6. [PMID: 2016090 DOI: 10.1007/BF00194640] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
424 Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999;45:834-9. [PMID: 10562581 DOI: 10.1136/gut.45.6.834] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
425 Tassi E, Wellstein A. Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas -. Cancer Res Treat 2006;38:189-97. [PMID: 19771241 DOI: 10.4143/crt.2006.38.4.189] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
426 Gordon JI. Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J Cell Biol 1989;108:1187-94. [PMID: 2647764 DOI: 10.1083/jcb.108.4.1187] [Cited by in Crossref: 159] [Cited by in F6Publishing: 176] [Article Influence: 5.0] [Reference Citation Analysis]
427 Yachida S, Mudali S, Martin SA, Montgomery EA, Iacobuzio-Donahue CA. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol. 2009;33:1823-1832. [PMID: 19745699 DOI: 10.1097/pas.0b013e3181b6da19] [Cited by in Crossref: 84] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
428 Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci USA. 1990;87:7737-7741. [PMID: 1977164 DOI: 10.1073/pnas.87.19.7737] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 2.3] [Reference Citation Analysis]
429 Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 1993;68:64-8. [PMID: 8318422 DOI: 10.1038/bjc.1993.287] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 2.0] [Reference Citation Analysis]
430 Wang X, Liu S, Cao H, Li X, Rong Y, Liu G, Du H, Shen H. Increasing Embryonic Morphogen Nodal Expression Suggests Malignant Transformation in Colorectal Lesions and as a Potential Marker for CMS4 Subtype of Colorectal Cancer. Pathol Oncol Res 2021;27:587029. [PMID: 34257534 DOI: 10.3389/pore.2021.587029] [Reference Citation Analysis]
431 Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS, Esserman LJ. Population-based screening for cancer: hope and hype. Nat Rev Clin Oncol 2016;13:550-65. [PMID: 27071351 DOI: 10.1038/nrclinonc.2016.50] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
432 Maestro R, Viel A, Boiocchi M. Correlation between chromosome 5q deletions and different mechanisms of c-myc overexpression in human colorectal cancer. Br J Cancer 1991;63:185-6. [PMID: 1847643 DOI: 10.1038/bjc.1991.45] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
433 Buettner R, Yim SO, Hong YS, Boncinelli E, Tainsky MA. Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells. Mol Cell Biol 1991;11:3573-83. [PMID: 1675427 DOI: 10.1128/mcb.11.7.3573-3583.1991] [Cited by in Crossref: 12] [Article Influence: 0.4] [Reference Citation Analysis]
434 Rubin H, Chow M, Yao A. Cellular aging, destabilization, and cancer. Proc Natl Acad Sci U S A 1996;93:1825-30. [PMID: 8700843 DOI: 10.1073/pnas.93.5.1825] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
435 Luu C, Heinrich EL, Duldulao M, Arrington AK, Fakih M, Garcia-Aguilar J, Kim J. TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. PLoS One. 2013;8:e70604. [PMID: 23936455 DOI: 10.1371/journal.pone.0070604] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
436 De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, Delrio P. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087-1096. [PMID: 26151224 DOI: 10.3892/or.2015.4108] [Cited by in Crossref: 141] [Cited by in F6Publishing: 119] [Article Influence: 23.5] [Reference Citation Analysis]
437 Klein CA. Selection and adaptation during metastatic cancer progression. Nature. 2013;501:365-372. [PMID: 24048069 DOI: 10.1038/nature12628] [Cited by in Crossref: 179] [Cited by in F6Publishing: 147] [Article Influence: 22.4] [Reference Citation Analysis]
438 van 't Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, Schrier PI, Bos JL. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989;9:3114-6. [PMID: 2674680 DOI: 10.1128/mcb.9.7.3114-3116.1989] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
439 Yokota T, Matsumoto S, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn J Cancer Res 1997;88:959-64. [PMID: 9414657 DOI: 10.1111/j.1349-7006.1997.tb00315.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
440 Schmidt S, Denk S, Wiegering A. Targeting Protein Synthesis in Colorectal Cancer. Cancers (Basel) 2020;12:E1298. [PMID: 32455578 DOI: 10.3390/cancers12051298] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
441 Abd El-Fattah AA, Sadik NAH, Shaker OG, Mohamed Kamal A. Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk. Mediators Inflamm 2018;2018:9853192. [PMID: 30498395 DOI: 10.1155/2018/9853192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
442 Ito S, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. Detection of tumor DNA in serum of colorectal cancer patients. Jpn J Cancer Res. 2002;93:1266-1269. [PMID: 12460469 DOI: 10.1111/j.1349-7006.2002.tb01233.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
443 Yoon YS, Kim JC. Recent applications of chemosensitivity tests for colorectal cancer treatment. World J Gastroenterol 2014;20:16398-408. [PMID: 25469008 DOI: 10.3748/wjg.v20.i44.16398] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
444 Jodal HC, Helsingen LM, Anderson JC, Lytvyn L, Vandvik PO, Emilsson L. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open 2019;9:e032773. [PMID: 31578199 DOI: 10.1136/bmjopen-2019-032773] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 11.5] [Reference Citation Analysis]
445 Mastracci TL, Boulos FI, Andrulis IL, Lam WL. Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer. Breast Cancer Res 2007;9:215. [PMID: 18036272 DOI: 10.1186/bcr1785] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
446 Nakae K, Mitomi H, Saito T, Takahashi M, Morimoto T, Hidaka Y, Sakamoto N, Yao T, Watanabe S. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors. World J Gastroenterol. 2012;18:5551-5559. [PMID: 23112547 DOI: 10.3748/wjg.v18.i39.5551] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
447 Raghav KP, Shetty AV, Kazmi SM, Zhang N, Morris J, Taggart M, Fournier K, Royal R, Mansfield P, Eng C, Wolff RA, Overman MJ. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist 2013;18:1270-7. [PMID: 24149137 DOI: 10.1634/theoncologist.2013-0186] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
448 Sakai E, Fukuyo M, Matsusaka K, Ohata K, Doi N, Takane K, Matsuhashi N, Fukushima J, Nakajima A, Kaneda A. TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumors. Cancer Sci 2016;107:820-7. [PMID: 26991699 DOI: 10.1111/cas.12930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
449 Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era. Therap Adv Gastroenterol 2020;13:1756284820920779. [PMID: 32523622 DOI: 10.1177/1756284820920779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
450 Siraj S, Masoodi T, Siraj AK, Azam S, Qadri Z, Ahmed SO, AlBalawy WN, Al-Obaisi KA, Parvathareddy SK, AlManea HM, AlHussaini HF, Abduljabbar A, Alhomoud S, Al-Dayel FH, Alkuraya FS, Al-Kuraya KS. Clonal Evolution and Timing of Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E2938. [PMID: 33053768 DOI: 10.3390/cancers12102938] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
451 Drew DA, Devers TJ, O'Brien MJ, Horelik NA, Levine J, Rosenberg DW. HD chromoendoscopy coupled with DNA mass spectrometry profiling identifies somatic mutations in microdissected human proximal aberrant crypt foci. Mol Cancer Res 2014;12:823-9. [PMID: 24651453 DOI: 10.1158/1541-7786.MCR-13-0624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
452 Zeinalian M, Hashemzadeh-Chaleshtori M, Salehi R, Emami MH. Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer. Adv Biomed Res 2018;7:28. [PMID: 29531926 DOI: 10.4103/abr.abr_185_16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
453 Bertagnolli MM, Redston M, Compton CC, Niedzwiecki D, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol. 2011;29:3153-3162. [PMID: 21747089 DOI: 10.1200/jco.2010.33.0092] [Cited by in Crossref: 124] [Cited by in F6Publishing: 55] [Article Influence: 12.4] [Reference Citation Analysis]
454 Yamaji Y, Mitsushima T, Ikuma H, Watabe H, Okamoto M, Kawabe T, Wada R, Doi H, Omata M. Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 2004;53:568-72. [PMID: 15016753 DOI: 10.1136/gut.2003.026112] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
455 Quinlan MP, Quatela SE, Philips MR, Settleman J. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion. Mol Cell Biol. 2008;28:2659-2674. [PMID: 18268007 DOI: 10.1128/mcb.01661-07] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
456 Yousefi M, Li L, Lengner CJ. Hierarchy and Plasticity in the Intestinal Stem Cell Compartment. Trends Cell Biol 2017;27:753-64. [PMID: 28732600 DOI: 10.1016/j.tcb.2017.06.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 11.8] [Reference Citation Analysis]
457 Goi T, Yamaguchi A, Nakagawara G, Urano T, Shiku H, Furukawa K. Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer 1998;77:466-71. [PMID: 9472645 DOI: 10.1038/bjc.1998.74] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
458 Upadhyaya G, Guba SC, Sih SA, Feinberg AP, Talpaz M, Kantarjian HM, Deisseroth AB, Emerson SG. Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 1991;88:2131-6. [PMID: 1721627 DOI: 10.1172/JCI115543] [Cited by in Crossref: 56] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
459 Goodman M, Fletcher RH, Doria-Rose VP, Jensen CD, Zebrowski AM, Becerra TA, Quinn VP, Zauber AG, Corley DA, Doubeni CA. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res 2015;4:541-51. [PMID: 26201973 DOI: 10.2217/cer.15.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
460 Araki Y, Nakamura K, Chijiiwa Y, Nawata H. Expression of the placenta-specific, 100 kDa ras GTPase activating protein in several human cancer cell lines and normal human tissues. Mol Cell Biochem 1997;175:195-204. [PMID: 9350052 DOI: 10.1023/a:1006871516961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
461 Kim RY, Xu H, Myllykangas S, Ji H. Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer. Per Med 2011;8:331-45. [PMID: 23662107 DOI: 10.2217/pme.11.16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
462 Arnason T, Pino MS, Yilmaz O, Kirley SD, Rueda BR, Chung DC, Zukerberg LR. Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice. Cancer Biol Ther 2013;14:672-8. [PMID: 23792637 DOI: 10.4161/cbt.25089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
463 Bennett MA, Kay EW, Mulcahy H, O'flaherty L, O'donoghue DP, Leader M, Croke DT. ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clin Mol Pathol 1995;48:M310-5. [PMID: 16696029 DOI: 10.1136/mp.48.6.m310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
464 Cartwright CA, Coad CA, Egbert BM. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 1994;93:509-15. [PMID: 7509341 DOI: 10.1172/JCI117000] [Cited by in Crossref: 99] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
465 Sena P, Fioresi R, Faglioni F, Losi L, Faglioni G, Roncucci L. Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images. Oncol Lett. 2019;18:6101-6107. [PMID: 31788084 DOI: 10.3892/ol.2019.10928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
466 Gerling M, Nousiainen K, Hautaniemi S, Krüger S, Fritzsche B, Homann N, Bruch HP, Auer G, Roblick UJ, Ried T, Habermann JK. Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis. Inflamm Bowel Dis 2013;19:691-703. [PMID: 23455720 DOI: 10.1097/MIB.0b013e31827eeaa4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
467 Sacco M, De Palma FDE, Guadagno E, Giglio MC, Peltrini R, Marra E, Manfreda A, Amendola A, Cassese G, Dinuzzi VP, Pegoraro F, Tropeano FP, Luglio G, De Palma GD. Serrated lesions of the colon and rectum: Emergent epidemiological data and molecular pathways. Open Med (Wars) 2020;15:1087-95. [PMID: 33336065 DOI: 10.1515/med-2020-0226] [Reference Citation Analysis]
468 Stefanius K, Ylitalo L, Tuomisto A, Kuivila R, Kantola T, Sirniö P, Karttunen TJ, Mäkinen MJ. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology. 2011;58:679-692. [PMID: 21457162 DOI: 10.1111/j.1365-2559.2011.03821.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
469 Sakai E, Nakajima A, Kaneda A. Accumulation of aberrant DNA methylation during colorectal cancer development. World J Gastroenterol 2014;20:978-87. [PMID: 24574770 DOI: 10.3748/wjg.v20.i4.978] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
470 Forsyth NR, Morales CP, Damle S, Boman B, Wright WE, Kopelovich L, Shay JW. Spontaneous immortalization of clinically normal colon-derived fibroblasts from a familial adenomatous polyposis patient. Neoplasia 2004;6:258-65. [PMID: 15153338 DOI: 10.1593/neo.4103] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
471 Tóth K, Wasserkort R, Sipos F, Kalmár A, Wichmann B, Leiszter K, Valcz G, Juhász M, Miheller P, Patai ÁV, Tulassay Z, Molnár B. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. PLoS One. 2014;9:e115415. [PMID: 25526039 DOI: 10.1371/journal.pone.0115415] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
472 Knudson AG Jr. The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis. Br J Cancer 1989;59:661-6. [PMID: 2660894 DOI: 10.1038/bjc.1989.137] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 2.2] [Reference Citation Analysis]
473 Li J, Chen X, Gong X, Liu Y, Feng H, Qiu L, Hu Z, Zhang J. A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor. BMC Genomics 2009;10:241. [PMID: 19463170 DOI: 10.1186/1471-2164-10-241] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
474 Tomlinson IP, Bodmer WF. Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis. J Clin Pathol 1996;49:386-90. [PMID: 8707952 DOI: 10.1136/jcp.49.5.386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
475 Venter DJ, Thomas DG. Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer 1991;63:753-7. [PMID: 1674878 DOI: 10.1038/bjc.1991.168] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
476 Dadduzio V, Basso M, Rossi S, Cenci T, Capodimonti S, Strippoli A, Orlandi A, Cerchiaro E, Schinzari G, Cassano A, Martini M, Barone C. KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study. Mol Diagn Ther 2016;20:65-74. [PMID: 26610798 DOI: 10.1007/s40291-015-0178-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
477 Mechler BM, Strand D, Kalmes A, Merz R, Schmidt M, Török I. Drosophila as a model system for molecular analysis of tumorigenesis. Environ Health Perspect 1991;93:63-71. [PMID: 1773803 DOI: 10.1289/ehp.919363] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
478 Schneider G, Lutz S, Henn W, Zang KD, Blin N. Search for putative suppressor genes in meningioma: significance of chromosome 22. Hum Genet 1992;88:579-82. [PMID: 1551661 DOI: 10.1007/BF00219348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
479 Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf) 2015;3:269-76. [PMID: 26337942 DOI: 10.1093/gastro/gov046] [Cited by in Crossref: 19] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
480 Lew JI, Guo Y, Kim RK, Vargish L, Michelassi F, Arenas RB. Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive. J Gastrointest. Surg. 2002;6:563-568. [PMID: 12127122 DOI: 10.1016/s1091-255x(01)00042-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
481 Makino H, Ushijima T, Kakiuchi H, Onda M, Ito N, Sugimura T, Nagao M. Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, 2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo]4,5-b]pyridine. Jpn J Cancer Res 1994;85:510-4. [PMID: 8014110 DOI: 10.1111/j.1349-7006.1994.tb02388.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
482 Marzouk O, Schofield J. Review of histopathological and molecular prognostic features in colorectal cancer. Cancers (Basel). 2011;3:2767-2810. [PMID: 24212832 DOI: 10.3390/cancers3022767] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
483 Fujiki H, Sueoka E, Suganuma M. Tumor promoters: from chemicals to inflammatory proteins. J Cancer Res Clin Oncol 2013;139:1603-14. [PMID: 23756937 DOI: 10.1007/s00432-013-1455-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
484 Kim SY, Choi EJ, Yun JA, Jung ES, Oh ST, Kim JG, Kang WK, Lee SH. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases. Int J Med Sci 2015;12:92-9. [PMID: 25589885 DOI: 10.7150/ijms.10497] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
485 Rajamanickam S, Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 2008;69:460-71. [PMID: 19884979 DOI: 10.1002/ddr.20276] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 8.1] [Reference Citation Analysis]
486 Parisi A, Porzio G, Pulcini F, Cannita K, Ficorella C, Mattei V, Delle Monache S. What Is Known about Theragnostic Strategies in Colorectal Cancer. Biomedicines 2021;9:140. [PMID: 33535557 DOI: 10.3390/biomedicines9020140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
487 Danielsen HE, Pradhan M, Novelli M. Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era. Nat Rev Clin Oncol. 2016;13:291-304. [PMID: 26598944 DOI: 10.1038/nrclinonc.2015.208] [Cited by in Crossref: 73] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
488 Watanabe H, Sawabu N, Ohta H, Satomura Y, Yamakawa O, Motoo Y, Okai T, Takahashi H, Wakabayashi T. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn J Cancer Res. 1993;84:961-965. [PMID: 8407563 DOI: 10.1111/j.1349-7006.1993.tb00185.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 1.9] [Reference Citation Analysis]
489 Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, Traulsen A, Nowak MA, Siegel C, Velculescu VE. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA. 2008;105:4283-4288. [PMID: 18337506 DOI: 10.1073/pnas.0712345105] [Cited by in Crossref: 561] [Cited by in F6Publishing: 460] [Article Influence: 43.2] [Reference Citation Analysis]
490 Carethers JM. Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer. J Gastrointest Surg 2012;16:1648-50. [PMID: 22760966 DOI: 10.1007/s11605-012-1942-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
491 Takahashi T, Futamura M, Yoshimi N, Sano J, Katada M, Takagi Y, Kimura M, Yoshioka T, Okano Y, Saji S. Centrosomal kinases, HsAIRK1 and HsAIRK3, are overexpressed in primary colorectal cancers. Jpn J Cancer Res 2000;91:1007-14. [PMID: 11050471 DOI: 10.1111/j.1349-7006.2000.tb00878.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 4.0] [Reference Citation Analysis]
492 Plentz RR, Wiemann SU, Flemming P, Meier PN, Kubicka S, Kreipe H, Manns MP, Rudolph KL. Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut. 2003;52:1304-1307. [PMID: 12912862 DOI: 10.1136/gut.52.9.1304] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
493 Lin J, Chuang CC, Zuo L. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets. Oncotarget. 2017;8:17328-17346. [PMID: 28061475 DOI: 10.18632/oncotarget.14461] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
494 Minobe K, Onda M, Iida A, Kasumi F, Sakamoto G, Nakamura Y, Emi M. Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer. Jpn J Cancer Res 1998;89:916-22. [PMID: 9818027 DOI: 10.1111/j.1349-7006.1998.tb00649.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
495 Causada-Calo NS, Gonzalez-Moreno EI, Bishay K, Shorr R, Dube C, Heitman SJ, Hilsden RJ, Rostom A, Walsh C, Anderson JT, Keswani RN, Scaffidi MA, Grover SC, Forbes N. Educational interventions are associated with improvements in colonoscopy quality indicators: a systematic review and meta-analysis.Endosc Int Open. 2020;8:E1321-E1331. [PMID: 33015334 DOI: 10.1055/a-1221-4922] [Reference Citation Analysis]
496 Midorikawa Y, Tsutsumi S, Taniguchi H, Ishii M, Kobune Y, Kodama T, Makuuchi M, Aburatani H. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis. Jpn J Cancer Res. 2002;93:636-643. [PMID: 12079511 DOI: 10.1111/j.1349-7006.2002.tb01301.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
497 Li P, Lin JE, Schulz S, Pitari GM, Waldman SA. Can colorectal cancer be prevented or treated by oral hormone replacement therapy? Curr Mol Pharmacol. 2009;2:285-292. [PMID: 20021465 DOI: 10.2174/1874467210902030285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
498 Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the search continues. Future Med Chem. 2011;3:1787-1808. [PMID: 22004085 DOI: 10.4155/fmc.11.121] [Cited by in Crossref: 266] [Cited by in F6Publishing: 227] [Article Influence: 29.6] [Reference Citation Analysis]
499 Jang JH, Balik E, Kirchoff D, Tromp W, Kumar A, Grieco M, Feingold DL, Cekic V, Njoh L, Whelan RL. Oncologic colorectal resection, not advanced endoscopic polypectomy, is the best treatment for large dysplastic adenomas. J Gastrointest Surg. 2012;16:165-71; discussion 171-2. [PMID: 22058042 DOI: 10.1007/s11605-011-1746-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
500 Chung CH, Wilentz RE, Polak MM, Ramsoekh TB, Noorduyn LA, Gouma DJ, Huibregtse K, Offerhaus GJ, Slebos RJ. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol 1996;49:460-4. [PMID: 8763258 DOI: 10.1136/jcp.49.6.460] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
501 Franke AJ, Skelton WP, Starr JS, Parekh H, Lee JJ, Overman MJ, Allegra C, George TJ. Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches. J Natl Cancer Inst 2019;111:1131-41. [PMID: 31322663 DOI: 10.1093/jnci/djz093] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 35.0] [Reference Citation Analysis]
502 Bond CE, Umapathy A, Buttenshaw RL, Wockner L, Leggett BA, Whitehall VL. Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers. PLoS One 2012;7:e47483. [PMID: 23110075 DOI: 10.1371/journal.pone.0047483] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
503 Wang Y, Wu J, Luo W, Zhang H, Shi G, Shen Y, Zhu Y, Ma C, Dai B, Ye D, Zhu Y. ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A. Cell Death Dis 2021;12:661. [PMID: 34210956 DOI: 10.1038/s41419-021-03947-7] [Reference Citation Analysis]
504 Clausson CM, Grundberg I, Weibrecht I, Nilsson M, Söderberg O. Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments. EPMA J 2012;3:7. [PMID: 22738217 DOI: 10.1007/s13167-012-0140-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
505 Kreidieh M, Mukherji D, Temraz S, Shamseddine A. Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions. Biomed Res Int 2020;2020:9037217. [PMID: 32090113 DOI: 10.1155/2020/9037217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
506 Zhang Z, Kim K, Li X, Moreno M, Sharp T, Goodheart MJ, Safe S, Dupuy AJ, Amendt BA. MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression. Mol Cancer Ther 2014;13:1942-51. [PMID: 24785257 DOI: 10.1158/1535-7163.MCT-13-1000] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
507 Eccles DM, Brett L, Lessells A, Gruber L, Lane D, Steel CM, Leonard RC. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer 1992;65:40-4. [PMID: 1310251 DOI: 10.1038/bjc.1992.8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 2.2] [Reference Citation Analysis]
508 Wong AL, Lim JS, Sinha A, Gopinathan A, Lim R, Tan CS, Soh T, Venkatesh S, Titin C, Sapari NS, Lee SC, Yong WP, Tan DS, Pang B, Wang TT, Zee YK, Soong R, Trnkova Z, Lathia C, Thiery JP, Wilhelm S, Jeffers M, Goh BC. Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib. J Transl Med. 2015;13:57. [PMID: 25889309 DOI: 10.1186/s12967-015-0405-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
509 Nagayama K, Watatani M. Analysis of genetic alterations related to the development and progression of breast carcinoma. Jpn J Cancer Res 1993;84:1159-64. [PMID: 7903963 DOI: 10.1111/j.1349-7006.1993.tb02816.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
510 van 't Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, Schrier PI, Bos JL. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989;9:3114-6. [PMID: 2674680 DOI: 10.1128/mcb.9.7.3114-3116.1989] [Cited by in Crossref: 204] [Article Influence: 6.4] [Reference Citation Analysis]
511 Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol 1991;11:3842-9. [PMID: 1712897 DOI: 10.1128/mcb.11.8.3842-3849.1991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 52] [Article Influence: 0.1] [Reference Citation Analysis]
512 Wong S, Lidums I, Rosty C, Ruszkiewicz A, Parry S, Win AK, Tomita Y, Vatandoust S, Townsend A, Patel D, Hardingham JE, Roder D, Smith E, Drew P, Marker J, Uylaki W, Hewett P, Worthley DL, Symonds E, Young GP, Price TJ, Young JP. Findings in young adults at colonoscopy from a hospital service database audit. BMC Gastroenterol 2017;17:56. [PMID: 28424049 DOI: 10.1186/s12876-017-0612-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
513 Deen KI, Silva H, Deen R, Chandrasinghe PC. Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol. 2016;8:481-488. [PMID: 27326317 DOI: 10.4251/wjgo.v8.i6.481] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 25] [Article Influence: 7.4] [Reference Citation Analysis]
514 Chien CC, Tu TC, Huang CJ, Yang SH, Lee CL. Lowly expressed ribosomal protein s19 in the feces of patients with colorectal cancer. ISRN Gastroenterol 2012;2012:394545. [PMID: 22272377 DOI: 10.5402/2012/394545] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
515 Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8:686-700. [PMID: 22009203 DOI: 10.1038/nrgastro.2011.173] [Cited by in Crossref: 381] [Cited by in F6Publishing: 336] [Article Influence: 38.1] [Reference Citation Analysis]
516 Katkoori VR, Jia X, Chatla C, Kumar S, Ponnazhagan S, Callens T, Messiaen L, Grizzle WE, Manne U. Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma. Front Biosci 2008;13:1050-61. [PMID: 17981610 DOI: 10.2741/2742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
517 Ong BA, Vega KJ, Houchen CW. Intestinal stem cells and the colorectal cancer microenvironment. World J Gastroenterol. 2014;20:1898-1909. [PMID: 24587669 DOI: 10.3748/wjg.v20.i8.1898] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
518 Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A 1994;91:8910-4. [PMID: 8090743 DOI: 10.1073/pnas.91.19.8910] [Cited by in Crossref: 263] [Cited by in F6Publishing: 210] [Article Influence: 9.7] [Reference Citation Analysis]
519 Picanço-Junior OM, Oliveira AL, Freire LT, Brito RB, Villa LL, Matos D. Association between human Papillomavirus and colorectal adenocarcinoma and its influence on tumor staging and degree of cell differentiation. Arq Bras Cir Dig 2014;27:172-6. [PMID: 25184765 DOI: 10.1590/s0102-67202014000300003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
520 Raghav K, Overman MJ. Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol. 2013;10:534-544. [PMID: 23897080 DOI: 10.1038/nrclinonc.2013.132] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 10.8] [Reference Citation Analysis]
521 Shin D, Lee J, Gong JR, Cho KH. Percolation transition of cooperative mutational effects in colorectal tumorigenesis. Nat Commun 2017;8:1270. [PMID: 29097710 DOI: 10.1038/s41467-017-01171-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
522 Szylberg Ł, Janiczek M, Popiel A, Marszałek A. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract 2015;2015:573814. [PMID: 25945086 DOI: 10.1155/2015/573814] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
523 Halberg RB, Dove WF. Polyclonal tumors in the mammalian intestine: are interactions among multiple initiated clones necessary for tumor initiation, growth, and progression? Cell Cycle 2007;6:44-51. [PMID: 17245117 DOI: 10.4161/cc.6.1.3651] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
524 Besson D, Pavageau AH, Valo I, Bourreau A, Bélanger A, Eymerit-Morin C, Moulière A, Chassevent A, Boisdron-Celle M, Morel A. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics. 2011;10:M111.009712. [PMID: 21986994 DOI: 10.1074/mcp.m111.009712] [Cited by in Crossref: 81] [Cited by in F6Publishing: 32] [Article Influence: 8.1] [Reference Citation Analysis]
525 Rees CJ, Rajasekhar PT, Wilson A, Close H, Rutter MD, Saunders BP, East JE, Maier R, Moorghen M, Muhammad U, Hancock H, Jayaprakash A, MacDonald C, Ramadas A, Dhar A, Mason JM. Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study. Gut. 2017;66:887-895. [PMID: 27196576 DOI: 10.1136/gutjnl-2015-310584] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 17.4] [Reference Citation Analysis]
526 Rosty C, Hewett DG, Brown IS, Leggett BA, Whitehall VL. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol. 2013;48:287-302. [PMID: 23208018 DOI: 10.1007/s00535-012-0720-y] [Cited by in Crossref: 101] [Cited by in F6Publishing: 82] [Article Influence: 11.2] [Reference Citation Analysis]
527 Jo BH, Chun YK. Heterogeneity of invasive ductal carcinoma: proposal for a hypothetical classification. J Korean Med Sci 2006;21:460-8. [PMID: 16778390 DOI: 10.3346/jkms.2006.21.3.460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
528 Scott N, Bell SM, Sagar P, Blair GE, Dixon MF, Quirke P. p53 expression and K-ras mutation in colorectal adenomas. Gut. 1993;34:621-624. [PMID: 8504962 DOI: 10.1136/gut.34.5.621] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
529 Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V. Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 2008;14:4726-4734. [PMID: 18676741 DOI: 10.1158/1078-0432.ccr-07-4921] [Cited by in Crossref: 348] [Cited by in F6Publishing: 207] [Article Influence: 26.8] [Reference Citation Analysis]
530 Greaves MF. Stem cell origins of leukaemia and curability. Br J Cancer 1993;67:413-23. [PMID: 8439493 DOI: 10.1038/bjc.1993.81] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 2.2] [Reference Citation Analysis]
531 Miki Y, Nishisho I, Miyoshi Y, Horii A, Ando H, Nakajima T, Utsunomiya J, Nakamura Y. Frequent loss of heterozygosity at the MCC locus on chromosome 5q21-22 in sporadic colorectal carcinomas. Jpn J Cancer Res 1991;82:1003-7. [PMID: 1682292 DOI: 10.1111/j.1349-7006.1991.tb01935.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
532 Benvenuto M, Sileri P, Rossi P, Masuelli L, Fantini M, Nanni M, Franceschilli L, Sconocchia G, Lanzilli G, Arriga R, Faggioni G, Lista F, Orlandi A, Manzari V, Gaspari AL, Modesti A, Bei R. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. J Transl Med 2015;13:101. [PMID: 25889931 DOI: 10.1186/s12967-015-0455-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
533 Stigliano V, Assisi D, Cosimelli M, Palmirotta R, Giannarelli D, Mottolese M, Mete LS, Mancini R, Casale V. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res 2008;27:39. [PMID: 18803843 DOI: 10.1186/1756-9966-27-39] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
534 Johnson RL, Fleet JC. Animal models of colorectal cancer. Cancer Metastasis Rev. 2013;32:39-61. [PMID: 23076650 DOI: 10.1007/s10555-012-9404-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
535 Pang SW, Awi NJ, Armon S, Lim WW, Low JS, Peh KB, Peh SC, Teow SY. Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC). Diagnostics (Basel) 2019;10:E9. [PMID: 31877940 DOI: 10.3390/diagnostics10010009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
536 Gaiser T, Meinhardt S, Hirsch D, Killian JK, Gaedcke J, Jo P, Ponsa I, Miró R, Rüschoff J, Seitz G. Molecular patterns in the evolution of serrated lesion of the colorectum. Int J Cancer. 2013;132:1800-1810. [PMID: 23011871 DOI: 10.1002/ijc.27869] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
537 Kerr IB. Molecular genetics of colorectal carcinoma. BMJ 1989;299:637-8. [PMID: 2508846 DOI: 10.1136/bmj.299.6700.637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
538 Takane K, Matsusaka K, Ota S, Fukuyo M, Yue Y, Nishimura M, Sakai E, Matsushita K, Miyauchi H, Aburatani H, Nakatani Y, Takayama T, Matsubara H, Akagi K, Kaneda A. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis. Oncotarget 2016;7:84003-16. [PMID: 27563825 DOI: 10.18632/oncotarget.11510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
539 Kim JJ, Hong KS, Kim JS, Jung HC. A Randomized Controlled Clinical Study Comparing the Diagnostic Accuracy of the Histologic Prediction for Colorectal Polyps Depending on the Use of Either Magnified or Nonmagnified Narrow Band Imaging. Clin Endosc 2015;48:528-33. [PMID: 26668800 DOI: 10.5946/ce.2015.48.6.528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
540 Lee SHF, Abdul Rahman H, Abidin N, Ong SK, Leong E, Naing L. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17. BMC Cancer 2021;21:477. [PMID: 33926405 DOI: 10.1186/s12885-021-08224-6] [Reference Citation Analysis]
541 Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, Xiao TL, Luo YH. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003;9:655-9. [PMID: 12679904 DOI: 10.3748/wjg.v9.i4.655] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
542 Weaver JMJ, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, Murtaza M, Ong CJ, Lao-Sirieix P, Dunning MJ. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet. 2014;46:837-843. [PMID: 24952744 DOI: 10.1038/ng.3013] [Cited by in Crossref: 216] [Cited by in F6Publishing: 173] [Article Influence: 30.9] [Reference Citation Analysis]
543 Li W, Hou Y, Ming M, Yu L, Seba A, Qian Z. Apc regulates the function of hematopoietic stem cells largely through β-catenin-dependent mechanisms. Blood 2013;121:4063-72. [PMID: 23547052 DOI: 10.1182/blood-2012-12-473470] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
544 Ajioka Y, Watanabe H, Jass JR, Yokota Y, Kobayashi M, Nishikura K. Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum. Gut. 1998;42:680-684. [PMID: 9659164 DOI: 10.1136/gut.42.5.680] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
545 Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A, Angriman I. Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World J Gastroenterol. 2014;20:6774-6785. [PMID: 24944468 DOI: 10.3748/wjg.v20.i22.6774] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
546 Lim B, Mun J, Kim JH, Kim CW, Roh SA, Cho DH, Kim YS, Kim SY, Kim JC. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels. Oncotarget 2015;6:22179-90. [PMID: 26109429 DOI: 10.18632/oncotarget.4246] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
547 Chen H, Liu L, Lu M, Zhang Y, Lu B, Zhu Y, Tian J, Li X, Nie S, Miao X, Dai M. Implications of Lifestyle Factors and Polygenic Risk Score for Absolute Risk Prediction of Colorectal Neoplasm and Risk-Adapted Screening. Front Mol Biosci 2021;8:685410. [PMID: 34336927 DOI: 10.3389/fmolb.2021.685410] [Reference Citation Analysis]
548 Huang CJ, Chien CC, Yang SH, Chang CC, Sun HL, Cheng YC, Liu CC, Lin SC, Lin CM. Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer. J Cell Mol Med 2008;12:1936-43. [PMID: 18266979 DOI: 10.1111/j.1582-4934.2008.00253.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
549 Biller LH, Ukaegbu C, Dhingra TG, Burke CA, Chertock Y, Chittenden A, Church JM, Koeppe ES, Leach BH, Levinson E, Lim RM, Lutz M, Salo-Mullen E, Sheikh R, Idos G, Kastrinos F, Stoffel E, Weiss JM, Hall MJ, Kalady MF, Stadler ZK, Syngal S, Yurgelun MB. A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. Cancer Prev Res (Phila) 2020;13:291-8. [PMID: 32051178 DOI: 10.1158/1940-6207.CAPR-19-0416] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
550 Siraj AK, Masoodi T, Bu R, Pratheeshkumar P, Al-Sanea N, Ashari LH, Abduljabbar A, Alhomoud S, Al-Dayel F, Alkuraya FS, Al-Kuraya KS. MED12 is recurrently mutated in Middle Eastern colorectal cancer. Gut 2018;67:663-71. [PMID: 28183795 DOI: 10.1136/gutjnl-2016-313334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
551 Afshari CA, Barrett JC. Cell cycle controls: potential targets for chemical carcinogens? Environ Health Perspect 1993;101 Suppl 5:9-14. [PMID: 8013430 DOI: 10.1289/ehp.93101s59] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
552 Satoh K, Sawai T, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Toyota T. The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas. Int J Pancreatol 1993;14:135-43. [PMID: 8283077 DOI: 10.1007/BF02786119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
553 Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-76. [DOI: 10.1038/ncb2048] [Cited by in Crossref: 1205] [Cited by in F6Publishing: 1094] [Article Influence: 109.5] [Reference Citation Analysis]
554 Gil Ferreira C, Aran V, Zalcberg-Renault I, Victorino AP, Salem JH, Bonamino MH, Vieira FM, Zalis M. KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients. BMC Gastroenterol 2014;14:73. [PMID: 24720724 DOI: 10.1186/1471-230X-14-73] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
555 Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992;11:95-103. [PMID: 1394797 DOI: 10.1007/BF00048057] [Cited by in Crossref: 389] [Cited by in F6Publishing: 48] [Article Influence: 13.4] [Reference Citation Analysis]
556 Kim K, Park U, Wang J, Lee J, Park S, Kim S, Choi D, Kim C, Park J. Gene profiling of colonic serrated adenomas by using oligonucleotide microarray. Int J Colorectal Dis. 2008;23:569-580. [PMID: 18305945 DOI: 10.1007/s00384-008-0451-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
557 Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JK, Markowitz SD, Morin P. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA. 1996;93:9049-9054. [PMID: 8799152 DOI: 10.1073/pnas.93.17.9049] [Cited by in Crossref: 205] [Cited by in F6Publishing: 178] [Article Influence: 8.2] [Reference Citation Analysis]
558 Sagaert X. Prognostic biomarkers in colorectal cancer: where do we stand? Virchows Arch. 2014;464:379-391. [PMID: 24487787 DOI: 10.1007/s00428-013-1532-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
559 Lee JK, Chan AT. Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status. Curr Colorectal Cancer Rep 2011;7:136-44. [PMID: 21572547 DOI: 10.1007/s11888-011-0091-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
560 Orr-Urtreger A, Trakhtenbrot L, Ben-Levy R, Wen D, Rechavi G, Lonai P, Yarden Y. Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc Natl Acad Sci U S A 1993;90:1867-71. [PMID: 8095334 DOI: 10.1073/pnas.90.5.1867] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 2.7] [Reference Citation Analysis]
561 Wang DX, Fang DC, Luo YH, Liu WW. Loss of heterozygosity and mRNA expression at deleted in colorectal cancer gene locus in gastric cancer. World J Gastroenterol 1997;3:156-9. [PMID: 27239131 DOI: 10.3748/wjg.v3.i3.156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ 2017;356:i6673. [PMID: 28087510 DOI: 10.1136/bmj.i6673] [Cited by in Crossref: 61] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
563 Oltedal S, Aasprong OG, Møller JH, Kørner H, Gilje B, Tjensvoll K, Birkemeyer EM, Heikkilä R, Smaaland R, Nordgård O. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. Int J Colorectal Dis 2011;26:1271-7. [PMID: 21573767 DOI: 10.1007/s00384-011-1233-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
564 Grade M, Difilippantonio MJ, Camps J. Patterns of Chromosomal Aberrations in Solid Tumors. Recent Results Cancer Res 2015;200:115-42. [PMID: 26376875 DOI: 10.1007/978-3-319-20291-4_6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
565 Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic Progression and Divergence in Pancreatic Carcinoma. Am J Pathol. 2000;156:2123-2133. [PMID: 10854233 DOI: 10.1016/s0002-9440(10)65083-3] [Cited by in Crossref: 106] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
566 Rubin H. Experimental control of neoplastic progression in cell populations: Foulds' rules revisited. Proc Natl Acad Sci U S A 1994;91:6619-23. [PMID: 8022827 DOI: 10.1073/pnas.91.14.6619] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
567 Jo P, Bernhardt M, Nietert M, König A, Azizian A, Schirmer MA, Grade M, Kitz J, Reuter-Jessen K, Ghadimi M, Ströbel P, Schildhaus HU, Gaedcke J. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer. PLoS One 2020;15:e0239806. [PMID: 33002027 DOI: 10.1371/journal.pone.0239806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
568 Betticher DC, Heighway J, Thatcher N, Hasleton PS. Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 1997;75:1761-8. [PMID: 9192978 DOI: 10.1038/bjc.1997.300] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
569 Kim EH, Kim HK, Bae SJ, Chang HS, Park HW, Do MY, Kim KJ, Jung CH, Lee WJ, Park JY, Choe J. Fasting serum insulin levels and insulin resistance are associated with colorectal adenoma in Koreans. J Diabetes Investig 2014;5:297-304. [PMID: 24843778 DOI: 10.1111/jdi.12178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
570 Huang CJ, Yang SH, Lee CL, Cheng YC, Tai SY, Chien CC. Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses. PLoS One 2013;8:e67043. [PMID: 23826192 DOI: 10.1371/journal.pone.0067043] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
571 Ishigooka S, Nomoto M, Obinata N, Oishi Y, Sato Y, Nakatsu S, Suzuki M, Ikeda Y, Maehata T, Kimura T. Evaluation of magnifying colonoscopy in the diagnosis of serrated polyps. World J Gastroenterol. 2012;18:4308-4316. [PMID: 22969193 DOI: 10.3748/wjg.v18.i32.4308] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
572 Bassoy EY, Chiusolo V, Jacquemin G, Riccadonna C, Walker PR, Martinvalet D. Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes. PLoS One 2016;11:e0153433. [PMID: 27073883 DOI: 10.1371/journal.pone.0153433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
573 Glazer E, Golla V, Forman R, Zhu H, Levi G, Bodenheimer HC Jr. Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci 2008;53:2204-7. [PMID: 18320324 DOI: 10.1007/s10620-007-0143-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
574 Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol. 1999;154:1849-1855. [PMID: 10362811 DOI: 10.1016/s0002-9440(10)65442-9] [Cited by in Crossref: 171] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
575 Groff RJ, Nash R, Ahnen DJ. Significance of serrated polyps of the colon. Curr Gastroenterol Rep. 2008;10:490-498. [PMID: 18799125 DOI: 10.1007/s11894-008-0090-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
576 Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK. The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 2005;50:42-6. [PMID: 15712635 DOI: 10.1007/s10620-005-1275-z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
577 Ahlquist DA. Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci. 2015;60:623-633. [PMID: 25492503 DOI: 10.1007/s10620-014-3451-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
578 Stallmach A, von Lampe B, Matthes H, Bornhöft G, Riecken EO. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut 1992;33:342-6. [PMID: 1568652 DOI: 10.1136/gut.33.3.342] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 3.5] [Reference Citation Analysis]
579 Shida Y, Ichikawa K, Fujimori T, Fujimori Y, Tomita S, Fujii T, Sano Y, Oda Y, Goto H, Ohta A, Tanaka S, Sugai T, Yao T, Ohkura Y, Imura J, Kato H. Differentiation between sessile serrated adenoma/polyp and non-sessile serrated adenoma/polyp in large hyper plastic polyp: A Japanese collaborative study. Mol Clin Oncol 2013;1:53-8. [PMID: 24649122 DOI: 10.3892/mco.2012.20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
580 Hibi K, Mizukami H, Shirahata A, Goto T, Sakata M, Sanada Y. Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer. World J Surg. 2009;33:1053-1057. [PMID: 19242752 DOI: 10.1007/s00268-008-9909-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
581 D'Abaco GM, Whitehead RH, Burgess AW. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol Cell Biol 1996;16:884-91. [PMID: 8622690 DOI: 10.1128/MCB.16.3.884] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
582 Cai K, Mulatz K, Ard R, Nguyen T, Gee SH. Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion. BMC Cancer 2014;14:208. [PMID: 24646293 DOI: 10.1186/1471-2407-14-208] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
583 Karagkounis G, Kalady MF. Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information? Clin Colon Rectal Surg 2017;30:415-22. [PMID: 29184477 DOI: 10.1055/s-0037-1606373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
584 Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer. 2011;104:1020-1026. [PMID: 21364579 DOI: 10.1038/bjc.2011.26] [Cited by in Crossref: 203] [Cited by in F6Publishing: 172] [Article Influence: 20.3] [Reference Citation Analysis]
585 Busby-Earle RM, Steel CM, Bird CC. Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies. Br J Cancer 1993;67:71-5. [PMID: 8094006 DOI: 10.1038/bjc.1993.11] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
586 Lizárraga-Verdugo E, Ruiz-García E, López-Camarillo C, Bermúdez M, Avendaño-Félix M, Ramos-Payán R, Romero-Quintana G, Ayala-Ham A, Villegas-Mercado C, Pérez-Plasencia C, Aguilar-Medina M. Cell Survival Is Regulated via SOX9/BCL2L1 Axis in HCT-116 Colorectal Cancer Cell Line. J Oncol 2020;2020:5701527. [PMID: 32411238 DOI: 10.1155/2020/5701527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
587 van Lidth de Jeude JF, Meijer BJ, Wielenga MCB, Spaan CN, Baan B, Rosekrans SL, Meisner S, Shen YH, Lee AS, Paton JC, Paton AW, Muncan V, van den Brink GR, Heijmans J. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells. Oncogene 2017;36:3397-405. [PMID: 27819675 DOI: 10.1038/onc.2016.326] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
588 Piepoli A, Cotugno R, Merla G, Gentile A, Augello B, Quitadamo M, Merla A, Panza A, Carella M, Maglietta R. Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour. BMC Med Genomics. 2009;2:11. [PMID: 19257893 DOI: 10.1186/1755-8794-2-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
589 Dickinson BT, Kisiel J, Ahlquist DA, Grady WM. Molecular markers for colorectal cancer screening. Gut. 2015;64:1485-1494. [PMID: 25994221 DOI: 10.1136/gutjnl-2014-308075] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 9.3] [Reference Citation Analysis]
590 Barone M, Tanzi S, Lofano K, Scavo MP, Guido R, Demarinis L, Principi MB, Bucci A, Di Leo A. Estrogens, phytoestrogens and colorectal neoproliferative lesions. Genes Nutr. 2008;3:7-13. [PMID: 18850193 DOI: 10.1007/s12263-008-0081-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
591 Bibi R, Pranesh N, Saunders MP, Wilson MS, O'dwyer ST, Stern PL, Renehan AG. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer 2006;95:1258-64. [PMID: 17031402 DOI: 10.1038/sj.bjc.6603398] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
592 Esteban-Jurado C, Garre P, Vila M, Lozano JJ, Pristoupilova A, Beltrán S, Abulí A, Muñoz J, Balaguer F, Ocaña T, Castells A, Piqué JM, Carracedo A, Ruiz-Ponte C, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S. New genes emerging for colorectal cancer predisposition. World J Gastroenterol 2014;20:1961-71. [PMID: 24587672 DOI: 10.3748/wjg.v20.i8.1961] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
593 Zheng GX, Lau BT, Schnall-Levin M, Jarosz M, Bell JM, Hindson CM, Kyriazopoulou-Panagiotopoulou S, Masquelier DA, Merrill L, Terry JM, Mudivarti PA, Wyatt PW, Bharadwaj R, Makarewicz AJ, Li Y, Belgrader P, Price AD, Lowe AJ, Marks P, Vurens GM, Hardenbol P, Montesclaros L, Luo M, Greenfield L, Wong A, Birch DE, Short SW, Bjornson KP, Patel P, Hopmans ES, Wood C, Kaur S, Lockwood GK, Stafford D, Delaney JP, Wu I, Ordonez HS, Grimes SM, Greer S, Lee JY, Belhocine K, Giorda KM, Heaton WH, McDermott GP, Bent ZW, Meschi F, Kondov NO, Wilson R, Bernate JA, Gauby S, Kindwall A, Bermejo C, Fehr AN, Chan A, Saxonov S, Ness KD, Hindson BJ, Ji HP. Haplotyping germline and cancer genomes with high-throughput linked-read sequencing. Nat Biotechnol 2016;34:303-11. [PMID: 26829319 DOI: 10.1038/nbt.3432] [Cited by in Crossref: 438] [Cited by in F6Publishing: 277] [Article Influence: 87.6] [Reference Citation Analysis]
594 Olde Loohuis L, Caravagna G, Graudenzi A, Ramazzotti D, Mauri G, Antoniotti M, Mishra B. Inferring tree causal models of cancer progression with probability raising. PLoS One 2014;9:e108358. [PMID: 25299648 DOI: 10.1371/journal.pone.0108358] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
595 Baker K, Zhang Y, Jin C, Jass JR. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol 2004;57:1089-93. [PMID: 15452166 DOI: 10.1136/jcp.2004.016600] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
596 Fazeli A, Steen RG, Dickinson SL, Bautista D, Dietrich WF, Bronson RT, Bresalier RS, Lander ES, Costa J, Weinberg RA. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci USA. 1997;94:10199-10204. [PMID: 9294187 DOI: 10.1073/pnas.94.19.10199] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 2.1] [Reference Citation Analysis]
597 Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol 2013;19:5286-94. [PMID: 23983431 DOI: 10.3748/wjg.v19.i32.5286] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
598 Simiantonaki N, Taxeidis M, Jayasinghe C, Kurzik-Dumke U, Kirkpatrick CJ. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer. 2008;8:320. [PMID: 18983642 DOI: 10.1186/1471-2407-8-320] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
599 Stoner GD, Morse MA, Kelloff GJ. Perspectives in cancer chemoprevention. Environ Health Perspect 1997;105 Suppl 4:945-54. [PMID: 9255586 DOI: 10.1289/ehp.97105s4945] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
600 Formica V, Cereda V, Nardecchia A, Tesauro M, Roselli M. Immune reaction and colorectal cancer: friends or foes? World J Gastroenterol. 2014;20:12407-12419. [PMID: 25253941 DOI: 10.3748/wjg.v20.i35.12407] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
601 Wang K, Zhu TN, Zhao RJ. Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration. Mol Med Rep 2019;20:3671-8. [PMID: 31485594 DOI: 10.3892/mmr.2019.10622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
602 Fujiki H, Sueoka E, Watanabe T, Suganuma M. Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J Cancer Prev 2015;20:1-4. [PMID: 25853098 DOI: 10.15430/JCP.2015.20.1.1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
603 Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM. Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the hum-an S3 ribosomal protein. Mol Cell Biol. 1991;11:3842-3849. [PMID: 1712897 DOI: 10.1128/MCB.11.8.3842] [Cited by in Crossref: 139] [Article Influence: 4.6] [Reference Citation Analysis]
604 Rochlitz CF, Heide I, de Kant E, Neubauer A, Schmidt CA, Neuhaus P, Huhn D, Herrmann R. Molecular alterations in a patient with Turcot's syndrome. Br J Cancer 1993;68:519-23. [PMID: 8394730 DOI: 10.1038/bjc.1993.379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
605 Su YH, Wang M, Brenner DE, Norton PA, Block TM. Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps. Ann N Y Acad Sci 2008;1137:197-206. [PMID: 18837947 DOI: 10.1196/annals.1448.027] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
606 Comalada M, Bailón E, de Haro O, Lara-Villoslada F, Xaus J, Zarzuelo A, Gálvez J. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol 2006;132:487-97. [PMID: 16788843 DOI: 10.1007/s00432-006-0092-x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 8.2] [Reference Citation Analysis]
607 Kashiwaba M, Tamura G, Suzuki Y, Maesawa C, Ogasawara S, Sakata K, Satodate R. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 1995;86:1054-9. [PMID: 8567396 DOI: 10.1111/j.1349-7006.1995.tb03020.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
608 Martinez JA, Prevot S, Nordlinger B, Nguyen TM, Lacarriere Y, Munier A, Lascu I, Vaillant JC, Capeau J, Lacombe ML. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 1995;37:712-20. [PMID: 8549951 DOI: 10.1136/gut.37.5.712] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 1.8] [Reference Citation Analysis]
609 Pai RK, Jayachandran P, Koong AC, Chang DT, Kwok S, Ma L, Arber DA, Balise RR, Tubbs RR, Shadrach B. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol. 2012;36:744-752. [PMID: 22314188 DOI: 10.1097/pas.0b013e31824430d7] [Cited by in Crossref: 121] [Cited by in F6Publishing: 58] [Article Influence: 13.4] [Reference Citation Analysis]
610 Padilla-Nash HM, Hathcock K, McNeil NE, Mack D, Hoeppner D, Ravin R, Knutsen T, Yonescu R, Wangsa D, Dorritie K, Barenboim L, Hu Y, Ried T. Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances. Genes Chromosomes Cancer 2012;51:353-74. [PMID: 22161874 DOI: 10.1002/gcc.21921] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
611 Yashiro T, Hara H, Fulton NC, Obara T, Kaplan EL. Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia. World J Surg 1994;18:455-60; discussion 460-1. [PMID: 7725728 DOI: 10.1007/BF00353735] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
612 Cenaj O, Gibson J, Odze RD. Clinicopathologic and outcome study of sessile serrated adenomas/polyps with serrated versus intestinal dysplasia. Mod Pathol 2018;31:633-42. [PMID: 29271414 DOI: 10.1038/modpathol.2017.169] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
613 Ounissi D, Weslati M, Boughriba R, Hazgui M, Bouraoui S. Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer. Turk J Med Sci 2021;51:148-58. [PMID: 32892548 DOI: 10.3906/sag-2003-42] [Reference Citation Analysis]
614 Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2015;308:G351-G363. [PMID: 25540232 DOI: 10.1152/ajpgi.00360.2012] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 15.3] [Reference Citation Analysis]
615 Burnett-Hartman AN, Newcomb PA, Phipps AI, Passarelli MN, Grady WM, Upton MP, Zhu LC, Potter JD. Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol. 2012;107:1213-1219. [PMID: 22688851 DOI: 10.1038/ajg.2012.167] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
616 Bos JL. From Ras to Rap and Back, a Journey of 35 Years. Cold Spring Harb Perspect Med 2018;8:a031468. [PMID: 28778969 DOI: 10.1101/cshperspect.a031468] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
617 Giaretti W, Rapallo A, Geido E, Sciutto A, Merlo F, Risio M, Rossini FP. Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation. Am J Pathol 1998;153:1201-9. [PMID: 9777951 DOI: 10.1016/S0002-9440(10)65664-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
618 Nakanishi Y, Diaz-Meco MT, Moscat J. Serrated Colorectal Cancer: The Road Less Travelled? Trends Cancer. 2019;5:742-754. [PMID: 31735291 DOI: 10.1016/j.trecan.2019.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
619 Wang JY, Hsieh JS, Chang MY, Huang TJ, Chen FM, Cheng TL, Alexandersen K, Huang YS, Tzou WS, Lin SR. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. World J Surg. 2004;28:721-726. [PMID: 15185002 DOI: 10.1007/s00268-004-7366-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 91] [Article Influence: 4.5] [Reference Citation Analysis]
620 Wang Y, Velho S, Vakiani E, Peng S, Bass AJ, Chu GC, Gierut J, Bugni JM, Der CJ, Philips M, Solit DB, Haigis KM. Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression. Cancer Discov 2013;3:294-307. [PMID: 23274911 DOI: 10.1158/2159-8290.CD-12-0198] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
621 Nandan MO, Yoon HS, Zhao W, Ouko LA, Chanchevalap S, Yang VW. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 2004;23:3404-13. [PMID: 15077182 DOI: 10.1038/sj.onc.1207397] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 5.9] [Reference Citation Analysis]
622 Hisamatsu T, McGuire M, Wu SY, Rupaimoole R, Pradeep S, Bayraktar E, Noh K, Hu W, Hansen JM, Lyons Y, Gharpure KM, Nagaraja AS, Mangala LS, Mitamura T, Rodriguez-Aguayo C, Eun YG, Rose J, Bartholomeusz G, Ivan C, Lee JS, Matsuo K, Frumovitz M, Wong KK, Lopez-Berestein G, Sood AK. PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. Mol Cancer Ther 2019;18:162-72. [PMID: 30305341 DOI: 10.1158/1535-7163.MCT-17-1050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
623 Hanski C. Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer 1995;72:1350-6. [PMID: 8519644 DOI: 10.1038/bjc.1995.514] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 2.5] [Reference Citation Analysis]
624 Konishi K, Fujii T, Boku N, Kato S, Koba I, Ohtsu A, Tajiri H, Ochiai A, Yoshida S. Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut. 1999;45:818-821. [PMID: 10562578 DOI: 10.1136/gut.45.6.818] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
625 Ishigooka S, Nomoto M, Obinata N, Oishi Y, Sato Y, Nakatsu S, Suzuki M, Ikeda Y, Maehata T, Kimura T. Evaluation of magnifying colonoscopy in the diagnosis of serrated polyps. World J Gastroenterol. 2012;18:4308-4316. [PMID: 22969193 DOI: 10.3748/wig.v18i32.4308] [Reference Citation Analysis]
626 Winawer SJ. The History of Colorectal Cancer Screening: A Personal Perspective. Dig Dis Sci 2015;60:596-608. [DOI: 10.1007/s10620-014-3466-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
627 Taunk P, Atkinson CD, Lichtenstein D, Rodriguez-Diaz E, Singh SK. Computer-assisted assessment of colonic polyp histopathology using probe-based confocal laser endomicroscopy. Int J Colorectal Dis. 2019;34:2043-2051. [PMID: 31696259 DOI: 10.1007/s00384-019-03406-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
628 Konishi K, Takimoto M, Kaneko K, Makino R, Hirayama Y, Nozawa H, Kurahashi T, Kumekawa Y, Yamamoto T, Ito H. BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias. Br J Cancer. 2006;94:311-317. [PMID: 16404419 DOI: 10.1038/sj.bjc.6602911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
629 Fine B, Hodakoski C, Koujak S, Su T, Saal LH, Maurer M, Hopkins B, Keniry M, Sulis ML, Mense S, Hibshoosh H, Parsons R. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 2009;325:1261-5. [PMID: 19729658 DOI: 10.1126/science.1173569] [Cited by in Crossref: 168] [Cited by in F6Publishing: 142] [Article Influence: 14.0] [Reference Citation Analysis]
630 Nagasaka T, Goel A, Notohara K, Takahata T, Sasamoto H, Uchida T, Nishida N, Tanaka N, Boland CR, Matsubara N. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer. 2008;122:2429-2436. [PMID: 18240147 DOI: 10.1002/ijc.23398] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
631 Boland CR, Ricciardiello L. How many mutations does it take to make a tumor? Proc Natl Acad Sci U S A 1999;96:14675-7. [PMID: 10611270 DOI: 10.1073/pnas.96.26.14675] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
632 Craanen ME, Blok P, Dekker W, Offerhaus GJ, Tytgat GN. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995;36:848-52. [PMID: 7615272 DOI: 10.1136/gut.36.6.848] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 1.6] [Reference Citation Analysis]
633 Yamada S, Ajioka Y, Watanabe H, Hashidate H, Takaku H, Kazama S, Yokoyama J, Nishikura K, Fujiwara T, Asakura H. Heterogeneity of p53 mutational status in intramucosal carcinoma of the colorectum. Jpn J Cancer Res 2001;92:161-6. [PMID: 11223545 DOI: 10.1111/j.1349-7006.2001.tb01078.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
634 Sakai E, Fukuyo M, Ohata K, Matsusaka K, Doi N, Mano Y, Takane K, Abe H, Yagi K, Matsuhashi N. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway. Int J Cancer. 2016;138:1634-1644. [PMID: 26510091 DOI: 10.1002/ijc.29903] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
635 Yoshida MA, Ikeuchi T, Iwama T, Miyaki M, Mori T, Ushijima Y, Hara A, Miyakita M, Tonomura A. Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991;82:916-21. [PMID: 1654311 DOI: 10.1111/j.1349-7006.1991.tb01921.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
636 Marchiò S, Soster M, Cardaci S, Muratore A, Bartolini A, Barone V, Ribero D, Monti M, Bovino P, Sun J, Giavazzi R, Asioli S, Cassoni P, Capussotti L, Pucci P, Bugatti A, Rusnati M, Pasqualini R, Arap W, Bussolino F. A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol Med 2012;4:1156-75. [PMID: 23070965 DOI: 10.1002/emmm.201101164] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
637 Fesler A, Zhang N, Ju J. The expanding regulatory universe of p53 in gastrointestinal cancer. F1000Res 2016;5:756. [PMID: 27508057 DOI: 10.12688/f1000research.8363.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
638 Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Siegal GP, Manne U. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior. J Histochem Cytochem 2008;56:305-12. [PMID: 18071066 DOI: 10.1369/jhc.7A7362.2007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
639 Nishikawa M, Oshitani N, Matsumoto T, Nishigami T, Arakawa T, Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br J Cancer. 2005;93:331-337. [PMID: 15956973 DOI: 10.1038/sj.bjc.6602664] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
640 Buchhop S, Gibson MK, Wang XW, Wagner P, Stürzbecher HW, Harris CC. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res 1997;25:3868-74. [PMID: 9380510 DOI: 10.1093/nar/25.19.3868] [Cited by in Crossref: 134] [Cited by in F6Publishing: 134] [Article Influence: 5.6] [Reference Citation Analysis]
641 Shackleford TJ, Claret FX. JAB1/CSN5: a new player in cell cycle control and cancer. Cell Div 2010;5:26. [PMID: 20955608 DOI: 10.1186/1747-1028-5-26] [Cited by in Crossref: 97] [Cited by in F6Publishing: 83] [Article Influence: 8.8] [Reference Citation Analysis]
642 Voorham QJ, Carvalho B, Spiertz AJ, Claes B, Mongera S, van Grieken NC, Grabsch H, Kliment M, Rembacken B, van de Wiel MA. Comprehensive mutation analysis in colorectal flat adenomas. PLoS One. 2012;7:e41963. [PMID: 22848674 DOI: 10.1371/journal.pone.0041963] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
643 Patai AV, Molnár B, Tulassay Z, Sipos F. Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol. 2013;19:607-615. [PMID: 23431044 DOI: 10.3748/wjg.v19.i5.607] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
644 Rainis T, Maor I, Lanir A, Shnizer S, Lavy A. Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 2007;52:526-30. [PMID: 17195121 DOI: 10.1007/s10620-006-9177-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
645 Roth S, Laiho P, Salovaara R, Launonen V, Aaltonen LA. No SMAD4 hypermethylation in colorectal cancer. Br J Cancer 2000;83:1015-9. [PMID: 10993648 DOI: 10.1054/bjoc.2000.1387] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
646 Summers RM. Polyp size measurement at CT colonography: what do we know and what do we need to know? Radiology. 2010;255:707-720. [PMID: 20501711 DOI: 10.1148/radiol.10090877] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
647 Mullin JM, Leatherman JM, Valenzano MC, Huerta ER, Verrechio J, Smith DM, Snetselaar K, Liu M, Francis MK, Sell C. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 2005;16:5538-50. [PMID: 16176977 DOI: 10.1091/mbc.e05-04-0294] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
648 Ando M, Maruyama M, Oto M, Takemura K, Endo M, Yuasa Y. Higher frequency of point mutations in the c-K-ras 2 gene in human colorectal adenomas with severe atypia than in carcinomas. Jpn J Cancer Res 1991;82:245-9. [PMID: 1708754 DOI: 10.1111/j.1349-7006.1991.tb01836.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.0] [Reference Citation Analysis]
649 Boland CR, Luciani MG, Gasche C, Goel A. Infection, inflammation, and gastrointestinal cancer. Gut. 2005;54:1321-1331. [PMID: 16099799 DOI: 10.1136/gut.2004.060079] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
650 Wallin U, Gunnarsson U, Glimelius B, Loktionov A, Påhlman L. Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer? Int J Colorectal Dis 2010;25:1071-8. [PMID: 20563588 DOI: 10.1007/s00384-010-0979-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
651 Shah A, Melhuish TA, Fox TE, Frierson HF Jr, Wotton D. TGIF transcription factors repress acetyl CoA metabolic gene expression and promote intestinal tumor growth. Genes Dev 2019;33:388-402. [PMID: 30808659 DOI: 10.1101/gad.320127.118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
652 Sugimura T, Wakabayashi K. Gastric carcinogenesis: diet as a causative factor. Med Oncol Tumor Pharmacother 1990;7:87-92. [PMID: 2232942 DOI: 10.1007/BF02988535] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
653 Satorres C, García-Campos M, Bustamante-Balén M. Molecular Features of the Serrated Pathway to Colorectal Cancer: Current Knowledge and Future Directions. Gut Liver 2021;15:31-43. [PMID: 32340435 DOI: 10.5009/gnl19402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
654 Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci U S A. 1999;96:4592-4597. [PMID: 10200307 DOI: 10.1073/pnas.96.8.4592] [Cited by in Crossref: 501] [Cited by in F6Publishing: 439] [Article Influence: 22.8] [Reference Citation Analysis]
655 Sandouk F, Al Jerf F, Al-Halabi MH. Precancerous lesions in colorectal cancer. Gastroenterol Res Pract. 2013;2013:457901. [PMID: 23737765 DOI: 10.1155/2013/457901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
656 Bauer VP, Papaconstantinou HT. Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg. 2008;21:273-279. [PMID: 20011438 DOI: 10.1055/s-0028-1089942] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
657 Matsuzaki K, Okazaki K. Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling. J Gastroenterol. 2006;41:295-303. [PMID: 16741607 DOI: 10.1007/s00535-006-1795-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
658 Qiu W, Schönleben F, Li X, Ho DJ, Close LG, Manolidis S, Bennett BP, Su GH. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 2006;12:1441-6. [PMID: 16533766 DOI: 10.1158/1078-0432.CCR-05-2173] [Cited by in Crossref: 148] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
659 Collisson EA, Cho RJ, Gray JW. What are we learning from the cancer genome? Nat Rev Clin Oncol 2012;9:621-30. [PMID: 22965149 DOI: 10.1038/nrclinonc.2012.159] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
660 Bumpers HL, Alosco TR, Wang HQ, Petrelli NJ, Hoover EL, Bankert RB. Human villous adenomas engrafted into scid mice survive for prolonged period without malignant transformation. J Clin Invest 1994;94:2153-7. [PMID: 7962563 DOI: 10.1172/JCI117572] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
661 Diaz-Uriarte R. Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling. BMC Bioinformatics 2015;16:41. [PMID: 25879190 DOI: 10.1186/s12859-015-0466-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
662 Herstad KMV, Moen AEF, Gaby JC, Moe L, Skancke E. Characterization of the fecal and mucosa-associated microbiota in dogs with colorectal epithelial tumors. PLoS One 2018;13:e0198342. [PMID: 29852000 DOI: 10.1371/journal.pone.0198342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
663 Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274-284. [PMID: 19308067 DOI: 10.1038/nrc2622] [Cited by in Crossref: 1692] [Cited by in F6Publishing: 1452] [Article Influence: 141.0] [Reference Citation Analysis]
664 McQueen HA, Wyllie AH, Piris J, Foster E, Bird CC. Stability of critical genetic lesions in human colorectal carcinoma xenografts. Br J Cancer 1991;63:94-6. [PMID: 1989671 DOI: 10.1038/bjc.1991.19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
665 Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. BMC Cancer 2013;13:439. [PMID: 24073892 DOI: 10.1186/1471-2407-13-439] [Cited by in Crossref: 28]